BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994-1002. [PMID: 22002980 DOI: 10.1093/cid/cir632] [Cited by in Crossref: 657] [Cited by in F6Publishing: 569] [Article Influence: 65.7] [Reference Citation Analysis]
Number Citing Articles
1 Bäckhed F, Fraser C, Ringel Y, Sanders M, Sartor R, Sherman P, Versalovic J, Young V, Finlay B. Defining a Healthy Human Gut Microbiome: Current Concepts, Future Directions, and Clinical Applications. Cell Host & Microbe 2012;12:611-22. [DOI: 10.1016/j.chom.2012.10.012] [Cited by in Crossref: 377] [Cited by in F6Publishing: 326] [Article Influence: 37.7] [Reference Citation Analysis]
2 Park JH. Clinical Usefulness of Fecal Microbiota Transplantation. J Neurogastroenterol Motil 2017;23:149-50. [PMID: 28249379 DOI: 10.5056/jnm17024] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Fuentes S, de Vos WM. How to Manipulate the Microbiota: Fecal Microbiota Transplantation. Adv Exp Med Biol 2016;902:143-53. [PMID: 27161356 DOI: 10.1007/978-3-319-31248-4_10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
4 Del Chierico F, Cardile S, Pietrobattista A, Liccardo D, Russo A, Candusso M, Basso MS, Grimaldi C, Pansani L, Bernaschi P, Torre G, Putignani L. Liver Transplantation and Gut Microbiota Profiling in a Child Colonized by a Multi-Drug Resistant Klebsiella pneumoniae: A New Approach to Move from Antibiotic to "Eubiotic" Control of Microbial Resistance. Int J Mol Sci 2018;19:E1280. [PMID: 29693574 DOI: 10.3390/ijms19051280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Bulow C, Langdon A, Hink T, Wallace M, Reske KA, Patel S, Sun X, Seiler S, Jones S, Kwon JH, Burnham CA, Dantas G, Dubberke ER. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential. mSphere 2018;3:e00588-18. [PMID: 30463925 DOI: 10.1128/mSphereDirect.00588-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
6 Oppfeldt AM, Dahlerup JF, Christensen LA, Hvas CL. Faecal microbiota transplantation for recurring Clostridium difficile infection in a patient with Crohn's disease and ileorectal anastomosis. BMJ Case Rep 2016;2016:bcr2016217209. [PMID: 27664230 DOI: 10.1136/bcr-2016-217209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tsutsumi LS, Owusu YB, Hurdle JG, Sun D. Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. Curr Top Med Chem 2014;14:152-75. [PMID: 24236721 DOI: 10.2174/1568026613666131113154753] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
8 Weiss S, Van Treuren W, Lozupone C, Faust K, Friedman J, Deng Y, Xia LC, Xu ZZ, Ursell L, Alm EJ, Birmingham A, Cram JA, Fuhrman JA, Raes J, Sun F, Zhou J, Knight R. Correlation detection strategies in microbial data sets vary widely in sensitivity and precision. ISME J 2016;10:1669-81. [PMID: 26905627 DOI: 10.1038/ismej.2015.235] [Cited by in Crossref: 324] [Cited by in F6Publishing: 267] [Article Influence: 54.0] [Reference Citation Analysis]
9 Pamer EG. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 2014;7:210-214. [PMID: 24399149 DOI: 10.1038/mi.2013.117] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
10 Suwantarat N, Bobak DA. Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again? Curr Infect Dis Rep. 2013;15:101-103. [PMID: 23549617 DOI: 10.1007/s11908-013-0314-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Zhou Y, Xu H, Huang H, Li Y, Chen H, He J, Du Y, Chen Y, Zhou Y, Nie Y. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? Biomed Res Int. 2019;2019:3469754. [PMID: 31467881 DOI: 10.1155/2019/3469754] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Merenstein D, El-Nachef N, Lynch SV. Fecal microbial therapy: promises and pitfalls. J Pediatr Gastroenterol Nutr 2014;59:157-61. [PMID: 24796803 DOI: 10.1097/MPG.0000000000000415] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
13 Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016;352:535-538. [PMID: 27126035 DOI: 10.1126/science.aad9382] [Cited by in Crossref: 207] [Cited by in F6Publishing: 182] [Article Influence: 34.5] [Reference Citation Analysis]
14 Sorbara MT, Pamer EG. Microbiome-based therapeutics. Nat Rev Microbiol 2022. [PMID: 34992261 DOI: 10.1038/s41579-021-00667-9] [Reference Citation Analysis]
15 Bruce-Keller AJ, Salbaum JM, Berthoud HR. Harnessing Gut Microbes for Mental Health: Getting From Here to There. Biol Psychiatry 2018;83:214-23. [PMID: 29031410 DOI: 10.1016/j.biopsych.2017.08.014] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 15.8] [Reference Citation Analysis]
16 Cole SA, Stahl TJ. Persistent and Recurrent Clostridium difficile Colitis. Clin Colon Rectal Surg 2015;28:65-9. [PMID: 26034401 DOI: 10.1055/s-0035-1547333] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
17 Sammons JS, Toltzis P. Recent trends in the epidemiology and treatment of C. difficile infection in children. Curr Opin Pediatr 2013;25:116-21. [PMID: 23241874 DOI: 10.1097/MOP.0b013e32835bf6c0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
18 Mandalia A, Kraft CS, Dhere T. Diverticulitis after fecal microbiota transplant for C. difficile infection. Am J Gastroenterol. 2014;109:1956-1957. [PMID: 25470590 DOI: 10.1038/ajg.2014.350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
19 Ramai D, Zakhia K, Ofosu A, Ofori E, Reddy M. Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness. Ann Gastroenterol 2019;32:30-8. [PMID: 30598589 DOI: 10.20524/aog.2018.0328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
20 Mullish B, Ghani R, Mcdonald J, Marchesi J. Faecal microbiota transplant for eradication of multidrug-resistant Enterobacteriaceae: a lesson in applying best practice? Re: ‘A five-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: A Randomized Clinical Trial’. Clinical Microbiology and Infection 2019;25:912-3. [DOI: 10.1016/j.cmi.2019.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Yang H, Cai R, Zhang Y, Chen Y, Gu B. Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile. Int J Nanomedicine 2020;15:6401-8. [PMID: 32904597 DOI: 10.2147/IJN.S268758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Verbeke F, Janssens Y, Wynendaele E, De Spiegeleer B. Faecal microbiota transplantation: a regulatory hurdle? BMC Gastroenterol 2017;17:128. [PMID: 29179687 DOI: 10.1186/s12876-017-0687-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
23 Kaplan BL, Li J, LaPres JJ, Pruett SB, Karmaus PW. Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology. Toxicol Sci 2015;145:214-32. [PMID: 26008184 DOI: 10.1093/toxsci/kfv060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
24 Wang S, Wang Y, Cai Y, Kelly CP, Sun X. Novel Chimeric Protein Vaccines Against Clostridium difficile Infection. Front Immunol 2018;9:2440. [PMID: 30405630 DOI: 10.3389/fimmu.2018.02440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Lagier J, Raoult D. Greffe de microbiote fécal et infections: Mise au point, perspectives. Med Sci (Paris) 2016;32:991-7. [DOI: 10.1051/medsci/20163211015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
26 Khuat LT, Dave M, Murphy WJ. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation. Gut Microbes 2021;13:1966262. [PMID: 34455917 DOI: 10.1080/19490976.2021.1966262] [Reference Citation Analysis]
27 Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJ, Keller JJ, Zoetendal EG, de Vos WM. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 2014;8:1621-1633. [PMID: 24577353 DOI: 10.1038/ismej.2014.13] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 15.6] [Reference Citation Analysis]
28 Thiemann S, Smit N, Strowig T. Antibiotics and the Intestinal Microbiome : Individual Responses, Resilience of the Ecosystem, and the Susceptibility to Infections. Curr Top Microbiol Immunol 2016;398:123-46. [PMID: 27738912 DOI: 10.1007/82_2016_504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
29 Zainah H, Silverman A. Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent  Clostridium difficile Infection. Case Rep Infect Dis 2012;2012:810943. [PMID: 22593832 DOI: 10.1155/2012/810943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
30 Nagy GG, Várvölgyi C, Paragh G. Successful treatment of life-threatening, treatment resistant Clostridium difficile infection associated pseudomembranous colitis with faecal transplantation. Orvosi Hetilap 2012;153:2077-83. [DOI: 10.1556/oh.2012.29509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 König J, Brummer R. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Beneficial Microbes 2014;5:247-61. [DOI: 10.3920/bm2013.0033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
32 Zhao S, Ghose-Paul C, Zhang K, Tzipori S, Sun X. Immune-based treatment and prevention of Clostridium difficile infection. Hum Vaccin Immunother. 2014;10:3522-3530. [PMID: 25668664 DOI: 10.4161/21645515.2014.980193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wang JW, Wang YK, Zhang F, Su YC, Wang JY, Wu DC, Hsu WH. Initial experience of fecal microbiota transplantation in gastrointestinal disease: A case series. Kaohsiung J Med Sci. 2019;35:566-571. [PMID: 31197926 DOI: 10.1002/kjm2.12094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
34 Crum-Cianflone NF, Sullivan E, Ballon-Landa G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol 2015;53:1986-9. [PMID: 25878340 DOI: 10.1128/JCM.00820-15] [Cited by in Crossref: 67] [Cited by in F6Publishing: 39] [Article Influence: 9.6] [Reference Citation Analysis]
35 Savin Z, Kivity S, Yonath H, Yehuda S. Smoking and the intestinal microbiome. Arch Microbiol 2018;200:677-84. [DOI: 10.1007/s00203-018-1506-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 21.3] [Reference Citation Analysis]
36 Walke JB, Becker MH, Loftus SC, House LL, Teotonio TL, Minbiole KP, Belden LK. Community Structure and Function of Amphibian Skin Microbes: An Experiment with Bullfrogs Exposed to a Chytrid Fungus. PLoS One 2015;10:e0139848. [PMID: 26445500 DOI: 10.1371/journal.pone.0139848] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
37 Vickers RJ, Tillotson G, Goldstein EJ, Citron DM, Garey KW, Wilcox MH. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents 2016;48:137-43. [PMID: 27283730 DOI: 10.1016/j.ijantimicag.2016.04.026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
38 Vandenplas Y, Pierard D, De Greef E. Fecal Microbiota Transplantation: Just a Fancy Trend? J Pediatr Gastroenterol Nutr. 2015;61:4-7. [PMID: 25905546 DOI: 10.1097/mpg.0000000000000816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Liu JY, Dickter JK. Nosocomial Infections: A History of Hospital-Acquired Infections. Gastrointest Endosc Clin N Am 2020;30:637-52. [PMID: 32891222 DOI: 10.1016/j.giec.2020.06.001] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wang Y, Wang S, Bouillaut L, Li C, Duan Z, Zhang K, Ju X, Tzipori S, Sonenshein AL, Sun X. Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters. Infect Immun 2018;86:e00489-18. [PMID: 30150259 DOI: 10.1128/IAI.00489-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Yang Z, Shi L, Yu H, Zhang Y, Chen K, Saint Fleur A, Bai G, Feng H. Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice from Clostridium difficile infection. Pathog Dis 2016;74:ftw078. [PMID: 27502696 DOI: 10.1093/femspd/ftw078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
42 Martin TC, Visconti A, Spector TD, Falchi M. Conducting metagenomic studies in microbiology and clinical research. Appl Microbiol Biotechnol 2018;102:8629-46. [PMID: 30078138 DOI: 10.1007/s00253-018-9209-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
43 Shin JH, Chaves-Olarte E, Warren CA. Clostridium difficile Infection. Microbiol Spectr 2016;4. [PMID: 27337475 DOI: 10.1128/microbiolspec.EI10-0007-2015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Fischer M, Kao D, Mehta SR, Martin T, Dimitry J, Keshteli AH, Cook GK, Phelps E, Sipe BW, Xu H, Kelly CR. Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study. American Journal of Gastroenterology 2016;111:1024-31. [DOI: 10.1038/ajg.2016.180] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
45 Jiang ZD, Hoang LN, Lasco TM, Garey KW, Dupont HL. Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis 2013;56:1059-60. [PMID: 23223589 DOI: 10.1093/cid/cis1025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
46 Kump PK, Gröchenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, Deutschmann A, Wenzl HH, Petritsch W, Krejs GJ. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis. 2013;19:2155-2165. [PMID: 23899544 DOI: 10.1097/mib.0b013e31829ea325] [Cited by in Crossref: 166] [Cited by in F6Publishing: 104] [Article Influence: 20.8] [Reference Citation Analysis]
47 Kump PK, Krause R, Allerberger F, Högenauer C. Faecal microbiota transplantation--the Austrian approach. Clin Microbiol Infect 2014;20:1106-11. [PMID: 25274251 DOI: 10.1111/1469-0691.12801] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
48 Mergenhagen KA, Wojciechowski AL, Paladino JA. A Review of the Economics of Treating Clostridium difficile Infection. PharmacoEconomics 2014;32:639-50. [DOI: 10.1007/s40273-014-0161-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
49 Bowman KA, Broussard EK, Surawicz CM. Fecal microbiota transplantation: current clinical efficacy and future prospects. Clin Exp Gastroenterol. 2015;8:285-291. [PMID: 26566371 DOI: 10.2147/ceg.s61305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
50 Aguirre M, Venema K. The art of targeting gut microbiota for tackling human obesity. Genes Nutr 2015;10:472. [PMID: 25991499 DOI: 10.1007/s12263-015-0472-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
51 Collins J, Auchtung JM, Schaefer L, Eaton KA, Britton RA. Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome 2015;3:35. [PMID: 26289776 DOI: 10.1186/s40168-015-0097-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
52 Gal A, Barko PC, Biggs PJ, Gedye KR, Midwinter AC, Williams DA, Burchell RK, Pazzi P. One dog's waste is another dog's wealth: A pilot study of fecal microbiota transplantation in dogs with acute hemorrhagic diarrhea syndrome. PLoS One 2021;16:e0250344. [PMID: 33872339 DOI: 10.1371/journal.pone.0250344] [Reference Citation Analysis]
53 Xu D, Li L, Zhang X, Yao H, Yang M, Gai Z, Li B, Zhao D. Degradation of Peptide-Bound Maillard Reaction Products in Gastrointestinal Digests of Glyoxal-Glycated Casein by Human Colonic Microbiota. J Agric Food Chem 2019;67:12094-104. [DOI: 10.1021/acs.jafc.9b03520] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Barathikannan K, Chelliah R, Rubab M, Daliri EB, Elahi F, Kim DH, Agastian P, Oh SY, Oh DH. Gut Microbiome Modulation Based on Probiotic Application for Anti-Obesity: A Review on Efficacy and Validation. Microorganisms 2019;7:E456. [PMID: 31623075 DOI: 10.3390/microorganisms7100456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
55 Ong GK, Reidy TJ, Huk MD, Lane FR. Clostridium difficile colitis: A clinical review. Am J Surg 2017;213:565-71. [PMID: 28131326 DOI: 10.1016/j.amjsurg.2016.10.035] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
56 Batista R, Kapel N, Megerlin F, Chaumeil J, Barbut F, Bourlioux P, Chast F. Le transfert de microbiote fécal lors d’infections récidivantes à Clostridium difficile. Cadre et aspects pharmacotechniques. Annales Pharmaceutiques Françaises 2015;73:323-31. [DOI: 10.1016/j.pharma.2015.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
57 Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis 2013;19:194-204. [PMID: 22508484 DOI: 10.1002/ibd.22964] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 9.7] [Reference Citation Analysis]
58 Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14:573-584. [PMID: 28743984 DOI: 10.1038/nrgastro.2017.88] [Cited by in Crossref: 451] [Cited by in F6Publishing: 405] [Article Influence: 90.2] [Reference Citation Analysis]
59 Kramer P, Bressan P. Humans as Superorganisms: How Microbes, Viruses, Imprinted Genes, and Other Selfish Entities Shape Our Behavior. Perspect Psychol Sci 2015;10:464-81. [PMID: 26177948 DOI: 10.1177/1745691615583131] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
60 Neves AL, Chilloux J, Sarafian MH, Rahim MB, Boulangé CL, Dumas ME. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases. Curr Opin Pharmacol 2015;25:36-44. [PMID: 26531326 DOI: 10.1016/j.coph.2015.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
61 Vuotto C, Barbanti F, Mastrantonio P, Donelli G. Lactobacillus brevis CD2 inhibits Prevotella melaninogenica biofilm. Oral Dis 2014;20:668-74. [DOI: 10.1111/odi.12186] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
62 Van Laar T, Boertien JM, Herranz AH. Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype? J Parkinsons Dis 2019;9:S371-9. [PMID: 31609702 DOI: 10.3233/JPD-191802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
63 Wenzler E, Mulugeta SG, Danziger LH. The Antimicrobial Stewardship Approach to Combating Clostridium Difficile. Antibiotics (Basel) 2015;4:198-215. [PMID: 27025621 DOI: 10.3390/antibiotics4020198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
64 DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm Bowel Dis. 2016;22:1137-1150. [PMID: 27070911 DOI: 10.1097/mib.0000000000000750] [Cited by in Crossref: 233] [Cited by in F6Publishing: 134] [Article Influence: 46.6] [Reference Citation Analysis]
65 Arulsamy A, Tan QY, Balasubramaniam V, O'Brien TJ, Shaikh MF. Gut Microbiota and Epilepsy: A Systematic Review on Their Relationship and Possible Therapeutics. ACS Chem Neurosci 2020;11:3488-98. [PMID: 33064448 DOI: 10.1021/acschemneuro.0c00431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Lagier JC. Faecal microbiota transplantation: from practice to legislation before considering industrialization. Clin Microbiol Infect 2014;20:1112-8. [PMID: 25273480 DOI: 10.1111/1469-0691.12795] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
67 Qu H, Jiang Z. Clostridium difficile infection in diabetes. Diabetes Research and Clinical Practice 2014;105:285-94. [DOI: 10.1016/j.diabres.2014.06.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
68 Cecil JA. Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures. Curr Infect Dis Rep. 2012;14:612-619. [PMID: 23054932 DOI: 10.1007/s11908-012-0298-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
69 Malani PN, Rao K. Expanded Evidence for Frozen Fecal Microbiota Transplantation for Clostridium difficile Infection: A Fresh Take. JAMA 2016;315:137-8. [PMID: 26757461 DOI: 10.1001/jama.2015.18100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
70 Noce A, Marrone G, Di Daniele F, Ottaviani E, Wilson Jones G, Bernini R, Romani A, Rovella V. Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases. Nutrients 2019;11:E1073. [PMID: 31091761 DOI: 10.3390/nu11051073] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
71 Kleger A, Schnell J, Essig A, Wagner M, Bommer M, Seufferlein T, Härter G. Fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int. 2013;110:108-115. [PMID: 23468820 DOI: 10.3238/arztebl.2013.0108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
72 Olle B. Medicines from microbiota. Nat Biotechnol 2013;31:309-15. [PMID: 23563425 DOI: 10.1038/nbt.2548] [Cited by in Crossref: 99] [Cited by in F6Publishing: 82] [Article Influence: 11.0] [Reference Citation Analysis]
73 Wang Y, Zheng F, Liu S, Luo H. Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome. Gastroenterol Res Pract 2019;2019:9759138. [PMID: 31885549 DOI: 10.1155/2019/9759138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
74 Waye A, Atkins K, Kao D. Cost Averted With Timely Fecal Microbiota Transplantation in the Management of Recurrent Clostridium difficile Infection in Alberta, Canada. J Clin Gastroenterol 2016;50:747-53. [PMID: 26890327 DOI: 10.1097/MCG.0000000000000494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
75 Shen N, Clemente JC. Engineering the Microbiome: a Novel Approach to Immunotherapy for Allergic and Immune Diseases. Curr Allergy Asthma Rep 2015;15:39. [PMID: 26143390 DOI: 10.1007/s11882-015-0538-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
76 Jackson M, Olefson S, Machan JT, Kelly CR. A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection. J Clin Gastroenterol. 2016;50:742-746. [PMID: 26565971 DOI: 10.1097/mcg.0000000000000447] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
77 Iacob S, Iacob DG. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis. Front Microbiol 2019;10:1676. [PMID: 31447793 DOI: 10.3389/fmicb.2019.01676] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
78 Dery KJ, Kadono K, Hirao H, Górski A, Kupiec-Weglinski JW. Microbiota in organ transplantation: An immunological and therapeutic conundrum? Cell Immunol 2020;351:104080. [PMID: 32139071 DOI: 10.1016/j.cellimm.2020.104080] [Reference Citation Analysis]
79 Barbut F, Guery B, Eckert C. Comment traiter une infection digestive à Clostridium difficile en 2014 ? Réanimation 2014;23:284-97. [DOI: 10.1007/s13546-014-0867-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 Evrensel A, Ceylan ME. Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders. Clin Psychopharmacol Neurosci 2016;14:231-7. [PMID: 27489376 DOI: 10.9758/cpn.2016.14.3.231] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
81 Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. Beneficial modulation of the gut microbiota. FEBS Lett 2014;588:4120-30. [PMID: 24681100 DOI: 10.1016/j.febslet.2014.03.035] [Cited by in Crossref: 150] [Cited by in F6Publishing: 130] [Article Influence: 18.8] [Reference Citation Analysis]
82 Brown WR. Fecal microbiota transplantation in treating Clostridium difficile infection: FMT in treating C. difficile infection. Journal of Digestive Diseases 2014;15:405-8. [DOI: 10.1111/1751-2980.12160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
83 Shields K, Araujo-Castillo RV, Theethira TG, Alonso CD, Kelly CP. Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe 2015;34:59-73. [PMID: 25930686 DOI: 10.1016/j.anaerobe.2015.04.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
84 Postigo R, Kim JH. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 2012;40:643-8. [PMID: 22847629 DOI: 10.1007/s15010-012-0307-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
85 Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013;1:3. [PMID: 24467987 DOI: 10.1186/2049-2618-1-3] [Cited by in Crossref: 462] [Cited by in F6Publishing: 404] [Article Influence: 51.3] [Reference Citation Analysis]
86 Huang EY, Devkota S, Moscoso D, Chang EB, Leone VA. The role of diet in triggering human inflammatory disorders in the modern age. Microbes Infect. 2013;15:765-774. [PMID: 23876436 DOI: 10.1016/j.micinf.2013.07.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
87 Andersen KK, Strokappe NM, Hultberg A, Truusalu K, Smidt I, Mikelsaar RH, Mikelsaar M, Verrips T, Hammarström L, Marcotte H. Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies. Infect Immun 2016;84:395-406. [PMID: 26573738 DOI: 10.1128/IAI.00870-15] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
88 Jarrad AM, Karoli T, Blaskovich MA, Lyras D, Cooper MA. Clostridium difficile drug pipeline: challenges in discovery and development of new agents. J Med Chem. 2015;58:5164-5185. [PMID: 25760275 DOI: 10.1021/jm5016846] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
89 Girotra M, Garg S, Anand R, Song Y, Dutta SK. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes. Dig Dis Sci. 2016;61:3007-3015. [PMID: 27447476 DOI: 10.1007/s10620-016-4229-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
90 Aminzadeh A, Tiwari MK, Mamah Mustapha SS, Navarrete SJ, Henriksen AB, Møller IM, Krogfelt KA, Bjerrum MJ, Jørgensen R. Detoxification of toxin A and toxin B by copper ion-catalyzed oxidation in production of a toxoid-based vaccine against Clostridioides difficile. Free Radic Biol Med 2020;160:433-46. [PMID: 32860983 DOI: 10.1016/j.freeradbiomed.2020.08.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Chiu YH, Lin SL, Tsai JJ, Lin MY. Probiotic actions on diseases: implications for therapeutic treatments. Food Funct 2014;5:625-34. [PMID: 24549263 DOI: 10.1039/c3fo60600g] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
92 McCarville JL, Caminero A, Verdu EF. Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol. 2016;9:580-593. [PMID: 27366225 DOI: 10.1177/1756283X16637819] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
93 Lagier JC, Delord M, Million M, Parola P, Stein A, Brouqui P, Raoult D. Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report. Eur J Clin Microbiol Infect Dis 2015;34:1597-601. [PMID: 25947205 DOI: 10.1007/s10096-015-2394-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
94 O'Connell KJ, Motherway MO, Liedtke A, Fitzgerald GF, Paul Ross R, Stanton C, Zomer A, van Sinderen D. Transcription of two adjacent carbohydrate utilization gene clusters in Bifidobacterium breve UCC2003 is controlled by LacI- and repressor open reading frame kinase (ROK)-type regulators. Appl Environ Microbiol 2014;80:3604-14. [PMID: 24705323 DOI: 10.1128/AEM.00130-14] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
95 Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterol Motil. 2015;27:19-29. [PMID: 25424663 DOI: 10.1111/nmo.12479] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
96 Hota SS, Surangiwala S, Paterson AS, Coburn B, Poutanen SM; Southern Ontario Fecal Microbiota Transplantation (SOFT) Movement*. Regional variability in fecal microbiota transplantation practices: a survey of the Southern Ontario Fecal Microbiota Transplantation Movement. CMAJ Open 2018;6:E184-90. [PMID: 29674329 DOI: 10.9778/cmajo.20170109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
97 Ebrahimzadeh S, Ahangari H, Soleimanian A, Hosseini K, Ebrahimi V, Ghasemnejad T, Soofiyani SR, Tarhriz V, Eyvazi S. Colorectal cancer treatment using bacteria: focus on molecular mechanisms. BMC Microbiol 2021;21:218. [PMID: 34281519 DOI: 10.1186/s12866-021-02274-3] [Reference Citation Analysis]
98 Almeida R, Gerbaba T, Petrof EO. Recurrent Clostridium difficile infection and the microbiome. J Gastroenterol 2016;51:1-10. [PMID: 26153514 DOI: 10.1007/s00535-015-1099-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
99 Fabbiano S, Suárez-Zamorano N, Trajkovski M. Host-Microbiota Mutualism in Metabolic Diseases. Front Endocrinol (Lausanne) 2017;8:267. [PMID: 29056925 DOI: 10.3389/fendo.2017.00267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
100 Elopre L, Rodriguez M. Fecal microbiota therapy for recurrent Clostridium difficile infection in HIV-infected persons. Ann Intern Med 2013;158:779-80. [PMID: 23689775 DOI: 10.7326/0003-4819-158-10-201305210-00021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
101 Dow DE, Seed PC. Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report. J Med Case Rep 2018;12:112. [PMID: 29703246 DOI: 10.1186/s13256-018-1659-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Kim KO, Gluck M. Fecal Microbiota Transplantation: An Update on Clinical Practice. Clin Endosc. 2019;52:137-143. [PMID: 30909689 DOI: 10.5946/ce.2019.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
103 Carmo J, Marques S, Chapim I, Túlio MA, Rodrigues JP, Bispo M, Chagas C. Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015. GE Port J Gastroenterol 2015;22:259-67. [PMID: 28868417 DOI: 10.1016/j.jpge.2015.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
104 Miller RR, Montoya V, Gardy JL, Patrick DM, Tang P. Metagenomics for pathogen detection in public health. Genome Med 2013;5:81. [PMID: 24050114 DOI: 10.1186/gm485] [Cited by in Crossref: 121] [Cited by in F6Publishing: 83] [Article Influence: 13.4] [Reference Citation Analysis]
105 Napolitano M, Covasa M. Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives. Front Microbiol 2020;11:590370. [PMID: 33304339 DOI: 10.3389/fmicb.2020.590370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Samuel BP, Crumb TL, Duba MM. What nurses need to know about fecal microbiota transplantation: education, assessment, and care for children and young adults. J Pediatr Nurs 2014;29:354-61. [PMID: 24582649 DOI: 10.1016/j.pedn.2014.01.013] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
107 Haindl R, Engel J, Kulozik U. Establishment of an In Vitro System of the Human Intestinal Microbiota: Effect of Cultivation Conditions and Influence of Three Donor Stool Samples. Microorganisms 2021;9:1049. [PMID: 34068085 DOI: 10.3390/microorganisms9051049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Dinh A, Bouchand F, Le Monnier A. Actualités épidémiologiques et thérapeutiques des infections à Clostridium difficile. La Revue de Médecine Interne 2015;36:596-602. [DOI: 10.1016/j.revmed.2015.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
109 Kachrimanidou M, Sarmourli T, Skoura L, Metallidis S, Malisiovas N. Clostridium difficile infection: New insights into therapeutic options. Crit Rev Microbiol 2016;42:773-9. [PMID: 25955884 DOI: 10.3109/1040841X.2015.1027171] [Reference Citation Analysis]
110 Orenstein R, Patron RL. Clostridioides difficile therapeutics: guidelines and beyond. Ther Adv Infect Dis 2019;6:2049936119868548. [PMID: 31448117 DOI: 10.1177/2049936119868548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
111 de Vos WM. Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes. Microb Biotechnol. 2013;6:316-325. [PMID: 23574632 DOI: 10.1111/1751-7915] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Vigvári S, Sipos D, Solt J, Vincze Á, Kocsis B, Nemes Z, Kappéter Á, Feiszt Z, Kovács B, Péterfi Z. Faecal microbiota transplantation for Clostridium difficile infection using a lyophilized inoculum from non-related donors: A case series involving 19 patients. Acta Microbiol Immunol Hung 2019;66:69-78. [PMID: 29239198 DOI: 10.1556/030.64.2017.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
113 Keller JJ, Ooijevaar RE, Hvas CL, Terveer EM, Lieberknecht SC, Högenauer C, Arkkila P, Sokol H, Gridnyev O, Mégraud F, Kump PK, Nakov R, Goldenberg SD, Satokari R, Tkatch S, Sanguinetti M, Cammarota G, Dorofeev A, Gubska O, Laniro G, Mattila E, Arasaradnam RP, Sarin SK, Sood A, Putignani L, Alric L, Baunwall SMD, Kupcinskas J, Link A, Goorhuis AG, Verspaget HW, Ponsioen C, Hold GL, Tilg H, Kassam Z, Kuijper EJ, Gasbarrini A, Mulder CJJ, Williams HRT, Vehreschild MJGT. A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterol J 2021;9:229-47. [PMID: 33151137 DOI: 10.1177/2050640620967898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
114 Nicholson MR, Mitchell PD, Alexander E, Ballal S, Bartlett M, Becker P, Davidovics Z, Docktor M, Dole M, Felix G, Gisser J, Hourigan SK, Jensen MK, Kaplan JL, Kelsen J, Kennedy M, Khanna S, Knackstedt E, Leier M, Lewis J, Lodarek A, Michail S, Oliva-Hemker M, Patton T, Queliza K, Russell GH, Singh N, Solomon A, Suskind DL, Werlin S, Kellermayer R, Kahn SA. Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. Clin Gastroenterol Hepatol 2020;18:612-619.e1. [PMID: 31009795 DOI: 10.1016/j.cgh.2019.04.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
115 Palmer BS, Metcalfe C, Fraser A, Creed T, Schumacher U. Does education influence the acceptability of faecal microbiota transplantation in colitis: A cross-sectional study. Cogent Medicine 2016;3:1233685. [DOI: 10.1080/2331205x.2016.1233685] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
116 Dias C, Pipa S, Duarte-Ribeiro F, Mota M. Fecal microbiota transplantation as a potential way to eradicate multiresistant microorganisms. IDCases 2018;13:e00432. [PMID: 30140609 DOI: 10.1016/j.idcr.2018.e00432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
117 Villéger R, Lopès A, Carrier G, Veziant J, Billard E, Barnich N, Gagnière J, Vazeille E, Bonnet M. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? Int J Mol Sci 2019;20:E4584. [PMID: 31533218 DOI: 10.3390/ijms20184584] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
118 Leung PC, Cheng KF. Fecal microbiota transplantation: Historical review and current perspective. World J Meta-Anal 2019; 7(9): 423-427 [DOI: 10.13105/wjma.v7.i9.423] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Shin JH, High KP, Warren CA. Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections. J Gerontol A Biol Sci Med Sci 2016;71:916-22. [PMID: 26809495 DOI: 10.1093/gerona/glv229] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
120 Yan LJ, Tang QY. Role of intestinal microbiota and fecal microbiota transplantation in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(9): 1386-1392 [DOI: 10.11569/wcjd.v24.i9.1386] [Reference Citation Analysis]
121 Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection. Can J Gastroenterol Hepatol 2014;28:319-24. [PMID: 24719899 DOI: 10.1155/2014/403828] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
122 Albarrak AA, Romana BS, Uraz S, Yousef MH, Juboori AA, Tahan V. Clostridium Difficile Infection in Inflammatory Bowel Disease Patients. Endocr Metab Immune Disord Drug Targets 2019;19:929-35. [PMID: 30827274 DOI: 10.2174/1871530319666190301120558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Richardson C, Kim P, Lee C, Bersenas A, Weese JS. Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection. Anaerobe 2015;33:105-8. [PMID: 25769665 DOI: 10.1016/j.anaerobe.2015.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
124 Brandt L. Faecal microbiota transplant. Gastrointestinal Nursing 2012;10:6-7. [DOI: 10.12968/gasn.2012.10.2.6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Costa MC, Weese JS. Understanding the Intestinal Microbiome in Health and Disease. Vet Clin North Am Equine Pract 2018;34:1-12. [PMID: 29402480 DOI: 10.1016/j.cveq.2017.11.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
126 Vigsnaes LK, Ghyselinck J, Van den Abbeele P, McConnell B, Moens F, Marzorati M, Bajic D. 2'FL and LNnT Exert Antipathogenic Effects against C. difficile ATCC 9689 In Vitro, Coinciding with Increased Levels of Bifidobacteriaceae and/or Secondary Bile Acids. Pathogens 2021;10:927. [PMID: 34451391 DOI: 10.3390/pathogens10080927] [Reference Citation Analysis]
127 Strauss R, Neurath MF. [Clostridium difficile infections - still a major challenge]. MMW Fortschr Med 2013;155:57-9. [PMID: 23668179 DOI: 10.1007/s15006-013-0436-9] [Reference Citation Analysis]
128 Montassier E, Al-Ghalith GA, Hillmann B, Viskocil K, Kabage AJ, McKinlay CE, Sadowsky MJ, Khoruts A, Knights D. CLOUD: a non-parametric detection test for microbiome outliers. Microbiome 2018;6:137. [PMID: 30081949 DOI: 10.1186/s40168-018-0514-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
129 Han SH, Yi J, Kim JH, Lee S, Moon HW. Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load. PLoS One 2019;14:e0212626. [PMID: 30785932 DOI: 10.1371/journal.pone.0212626] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
130 Gweon TG, Kim J, Lim CH, Park JM, Lee DG, Lee IS, Cho YS, Kim SW, Choi MG. Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe Complicated Clostridium difficile Infection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country. Gastroenterol Res Pract 2016;2016:2687605. [PMID: 27127501 DOI: 10.1155/2016/2687605] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
131 Tschudin-Sutter S, Widmer AF, Perl TM. Clostridium difficile: novel insights on an incessantly challenging disease. Curr Opin Infect Dis. 2012;25:405-411. [PMID: 22614522 DOI: 10.1097/qco.0b013e32835533a2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
132 Vindigni SM, Broussard EK, Surawicz CM. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Review of Gastroenterology & Hepatology 2014;7:615-28. [DOI: 10.1586/17474124.2013.832501] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
133 Foo JL, Ling H, Lee YS, Chang MW. Microbiome engineering: Current applications and its future. Biotechnol J 2017;12. [PMID: 28133942 DOI: 10.1002/biot.201600099] [Cited by in Crossref: 72] [Cited by in F6Publishing: 40] [Article Influence: 14.4] [Reference Citation Analysis]
134 Weingarden AR, Dosa PI, DeWinter E, Steer CJ, Shaughnessy MK, Johnson JR, Khoruts A, Sadowsky MJ. Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth. PLoS One 2016;11:e0147210. [PMID: 26789728 DOI: 10.1371/journal.pone.0147210] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 13.5] [Reference Citation Analysis]
135 Neemann K, Eichele DD, Smith PW, Bociek R, Akhtari M, Freifeld A. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012;14:E161-E165. [PMID: 23121625 DOI: 10.1111/tid.12017] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]
136 Malnick S, Melzer E. Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol 2015; 6(3): 79-85 [PMID: 26301122 DOI: 10.4291/wjgp.v6.i3.79] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
137 Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology. 2014;146:1573-1582. [PMID: 24412527 DOI: 10.1053/j.gastro.2014.01.004] [Cited by in Crossref: 125] [Cited by in F6Publishing: 108] [Article Influence: 15.6] [Reference Citation Analysis]
138 Major G, Spiller R. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes. 2014;21:15-21. [PMID: 24296462 DOI: 10.1097/med.0000000000000032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
139 Surawicz CM. Infection: treating recurrent C. difficile infection-the challenge continues. Nat Rev Gastroenterol Hepatol 2013;10:10-1. [PMID: 23207992 DOI: 10.1038/nrgastro.2012.240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
140 König J, Siebenhaar A, Högenauer C, Arkkila P, Nieuwdorp M, Norén T, Ponsioen CY, Rosien U, Rossen NG, Satokari R, Stallmach A, de Vos W, Keller J, Brummer RJ. Consensus report: faecal microbiota transfer - clinical applications and procedures. Aliment Pharmacol Ther 2017;45:222-39. [PMID: 27891639 DOI: 10.1111/apt.13868] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 12.0] [Reference Citation Analysis]
141 Terveer EM, van Beurden YH, Goorhuis A, Mulder CJJ, Kuijper EJ, Keller JJ; Working Group of The Netherlands Donor Feces Bank. Faecal microbiota transplantation in clinical practice. Gut 2018;67:196. [PMID: 28274998 DOI: 10.1136/gutjnl-2017-313909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
142 Shen Z, Zhu C, Quan Y, Yuan W, Wu S, Yang Z, Luo W, Tan B, Wang X. Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook. J Gastroenterol Hepatol. 2017;32:1804-1812. [PMID: 28677158 DOI: 10.1111/jgh.13861] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
143 Drekonja DM. Clostridium difficile infection: current, forgotten and emerging treatment options. J Comp Eff Res 2014;3:547-57. [PMID: 25350805 DOI: 10.2217/cer.14.36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
144 Kelly BJ, Tebas P. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. Chest. 2018;153:266-277. [PMID: 28923757 DOI: 10.1016/j.chest.2017.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
145 Jiang ZD, Ajami NJ, Petrosino JF, Jun G, Hanis CL, Shah M, Hochman L, Ankoma-Sey V, DuPont AW, Wong MC, Alexander A, Ke S, DuPont HL. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy. Aliment Pharmacol Ther. 2017;45:899-908. [PMID: 28220514 DOI: 10.1111/apt.13969] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 20.4] [Reference Citation Analysis]
146 Wang W, Xu AL, Li ZC, Li Y, Xu SF, Sang HC, Zhi F. Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. Diabetes Metab J 2020;44:336-48. [PMID: 31950772 DOI: 10.4093/dmj.2019.0042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
147 Rao K, Young VB. Fecal microbiota transplantation for the management of Clostridium difficile infection. Infect Dis Clin North Am 2015;29:109-22. [PMID: 25677705 DOI: 10.1016/j.idc.2014.11.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
148 Borody TJ, Peattie D, Mitchell SW. Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond. Antibiotics (Basel). 2015;4:254-266. [PMID: 27025624 DOI: 10.3390/antibiotics4030254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
149 Kubinak JL, Stephens WZ, Soto R, Petersen C, Chiaro T, Gogokhia L, Bell R, Ajami NJ, Petrosino JF, Morrison L, Potts WK, Jensen PE, O'Connell RM, Round JL. MHC variation sculpts individualized microbial communities that control susceptibility to enteric infection. Nat Commun 2015;6:8642. [PMID: 26494419 DOI: 10.1038/ncomms9642] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 11.3] [Reference Citation Analysis]
150 Manges AR, Steiner TS, Wright AJ. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review. Infect Dis (Lond). 2016;48:587-592. [PMID: 27194400 DOI: 10.1080/23744235.2016.1177199] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 11.2] [Reference Citation Analysis]
151 Gupta A, Khanna S. Ipilimumab-associated colitis or refractory Clostridium difficile infection? BMJ Case Rep. 2015;2015. [PMID: 26153295 DOI: 10.1136/bcr-2015-211160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
152 Martin J, Mawer D, Wilcox MH. Clostridium difficile: biological therapies. Curr Opin Infect Dis 2013;26:454-60. [PMID: 23982236 DOI: 10.1097/01.qco.0000433319.82618.8f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
153 Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, Abu-Zidan FM, Ansaloni L, Augustin G, Bala M, Ben-Ishay O, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cortese F, Cui Y, Czepiel J, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckmann C, Eiland EH, Forrester JD, Fraga GP, Frossard JL, Fry DE, Galeiras R, Ghnnam W, Gomes CA, Griffiths EA, Guirao X, Ahmed MH, Herzog T, Kim JI, Iqbal T, Isik A, Itani KMF, Labricciosa FM, Lee YY, Juang P, Karamarkovic A, Kim PK, Kluger Y, Leppaniemi A, Lohsiriwat V, Machain GM, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Ordoñez CA, Pagani L, Petrosillo N, Portela F, Rasa K, Rems M, Sakakushev BE, Segovia-Lohse H, Sganga G, Shelat VG, Spigaglia P, Tattevin P, Tranà C, Urbánek L, Ulrych J, Viale P, Baiocchi GL, Catena F. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg 2019;14:8. [PMID: 30858872 DOI: 10.1186/s13017-019-0228-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 15.7] [Reference Citation Analysis]
154 Holmes E, Kinross J, Gibson GR, Burcelin R, Jia W, Pettersson S, Nicholson JK. Therapeutic Modulation of Microbiota-Host Metabolic Interactions. Science Translational Medicine 2012;4:137rv6-137rv6. [DOI: 10.1126/scitranslmed.3004244] [Cited by in Crossref: 159] [Cited by in F6Publishing: 141] [Article Influence: 15.9] [Reference Citation Analysis]
155 Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation. Diseases 2020;8:E9. [PMID: 32326509 DOI: 10.3390/diseases8020009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
156 Matijašić M, Meštrović T, Perić M, Čipčić Paljetak H, Panek M, Vranešić Bender D, Ljubas Kelečić D, Krznarić Ž, Verbanac D. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Int J Mol Sci 2016;17:E578. [PMID: 27104515 DOI: 10.3390/ijms17040578] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
157 Zhang JZ, Bao CH, Shi Z, Weng ZJ, Wang XM, Wu LY, Wu HG. Role of intestinal microbiota in pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(33): 4505-4513 [DOI: 10.11569/wcjd.v24.i33.4505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Yang Z, Bu C, Yuan W, Shen Z, Quan Y, Wu S, Zhu C, Wang X. Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn’s Disease. Dig Dis Sci 2020;65:150-7. [DOI: 10.1007/s10620-019-05751-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
159 Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015;41:835-843. [PMID: 25728808 DOI: 10.1111/apt.13144] [Cited by in Crossref: 331] [Cited by in F6Publishing: 297] [Article Influence: 47.3] [Reference Citation Analysis]
160 Paknikar R, Pekow J. Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection. Surg Infect (Larchmt). 2018;19:785-791. [PMID: 30300561 DOI: 10.1089/sur.2018.221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
161 Trifan A, Stoica O, Stanciu C, Cojocariu C, Singeap AM, Girleanu I, Miftode E. Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis 2015;34:2313-24. [PMID: 26440041 DOI: 10.1007/s10096-015-2501-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
162 Koenigsknecht MJ, Young VB. Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs. Curr Opin Gastroenterol 2013;29:628-32. [PMID: 24100717 DOI: 10.1097/MOG.0b013e328365d326] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
163 Thomson P, Núñez P, Quera R, Bay C. Gastrointestinal microbiome, what is behind faecal microbiota transplantation? New Microbes New Infect 2021;42:100898. [PMID: 34168881 DOI: 10.1016/j.nmni.2021.100898] [Reference Citation Analysis]
164 Dickinson B, Surawicz CM. Infectious diarrhea: an overview. Curr Gastroenterol Rep. 2014;16:399. [PMID: 25064318 DOI: 10.1007/s11894-014-0399-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
165 Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016;9:606-625. [PMID: 27366227 DOI: 10.1177/1756283x16644242] [Cited by in Crossref: 89] [Cited by in F6Publishing: 55] [Article Influence: 14.8] [Reference Citation Analysis]
166 Faivre B, Bellenger J, Rieu A, Guivier E, Galan M, Ollivier A, Poloni L, Sorci G. Disentangling the effect of host genetics and gut microbiota on resistance to an intestinal parasite. International Journal for Parasitology 2019;49:873-83. [DOI: 10.1016/j.ijpara.2019.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
167 Jarett JK, Carlson A, Rossoni Serao M, Strickland J, Serfilippi L, Ganz HH. Diets with and without edible cricket support a similar level of diversity in the gut microbiome of dogs. PeerJ 2019;7:e7661. [PMID: 31565574 DOI: 10.7717/peerj.7661] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
168 Voth E, Khanna S. Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection. Expert Rev Anti Infect Ther 2020;18:669-76. [PMID: 32266848 DOI: 10.1080/14787210.2020.1752192] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
169 Gens KD, Elshaboury RH, Holt JS. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection. J Pharm Pract 2013;26:498-505. [PMID: 23966282 DOI: 10.1177/0897190013499527] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
170 Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013;4:125-35. [PMID: 23333862 DOI: 10.4161/gmic.23571] [Cited by in Crossref: 206] [Cited by in F6Publishing: 190] [Article Influence: 22.9] [Reference Citation Analysis]
171 Ng SC, Kamm MA, Yeoh YK, Chan PKS, Zuo T, Tang W, Sood A, Andoh A, Ohmiya N, Zhou Y, Ooi CJ, Mahachai V, Wu CY, Zhang F, Sugano K, Chan FKL. Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE). Gut 2020;69:83-91. [PMID: 31611298 DOI: 10.1136/gutjnl-2019-319407] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
172 Lan N, Ashburn J, Shen B. Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches. Gastroenterol Rep (Oxf). 2017;5:200-207. [PMID: 28852524 DOI: 10.1093/gastro/gox018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
173 Winichakoon P, Chaiwarith R, Chattipakorn N, Chattipakorn SC. Impact of gut microbiota on kidney transplantation. Transplant Rev (Orlando) 2021;36:100668. [PMID: 34688985 DOI: 10.1016/j.trre.2021.100668] [Reference Citation Analysis]
174 Moossavi S, Zhang H, Sun J, Rezaei N. Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer. Expert Rev Clin Immunol. 2013;9:409-422. [PMID: 23634736 DOI: 10.1586/eci.13.27] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
175 Yoon MY, Min KB, Lee KM, Yoon Y, Kim Y, Oh YT, Lee K, Chun J, Kim BY, Yoon SH, Lee I, Kim CY, Yoon SS. A single gene of a commensal microbe affects host susceptibility to enteric infection. Nat Commun 2016;7:11606. [PMID: 27173141 DOI: 10.1038/ncomms11606] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
176 Lyons J, Herring CA, Banerjee A, Simmons AJ, Lau KS. Multiscale analysis of the murine intestine for modeling human diseases. Integr Biol (Camb) 2015;7:740-57. [PMID: 26040649 DOI: 10.1039/c5ib00030k] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
177 Basso PJ, Câmara NOS, Sales-Campos H. Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human Studies. Front Pharmacol 2018;9:1571. [PMID: 30687107 DOI: 10.3389/fphar.2018.01571] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
178 Cheng YW, Fischer M. Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Clostridium difficile Infection. Clin Colon Rectal Surg 2020;33:92-7. [PMID: 32104162 DOI: 10.1055/s-0040-1701233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
179 Broecker F, Klumpp J, Schuppler M, Russo G, Biedermann L, Hombach M, Rogler G, Moelling K. Long-term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation. Cold Spring Harb Mol Case Stud 2016;2:a000448. [PMID: 27148577 DOI: 10.1101/mcs.a000448] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
180 Trubiano JA, George A, Barnett J, Siwan M, Heriot A, Prince HM, Slavin MA, Teh BW. A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma. Leukemia & Lymphoma 2014;56:512-4. [DOI: 10.3109/10428194.2014.920503] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
181 Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. Gut Microbes. 2017;8:225-237. [PMID: 28129018 DOI: 10.1080/19490976.2017.1286006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
182 Cui BT, Wang M, Ji GZ, Fan ZN, Zhang FM. Fecal microbiota transplantation: from the 4th century to 2013. Shijie Huaren Xiaohua Zazhi 2013; 21(30): 3222-3229 [DOI: 10.11569/wcjd.v21.i30.3222] [Reference Citation Analysis]
183 Trubiano JA, Cheng AC, Korman TM, Roder C, Campbell A, May ML, Blyth CC, Ferguson JK, Blackmore TK, Riley TV, Athan E. Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand. Intern Med J 2016;46:479-93. [PMID: 27062204 DOI: 10.1111/imj.13027] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 12.4] [Reference Citation Analysis]
184 Kruis W. Specific probiotics or ‘fecal transplantation’. Dig Dis. 2012;30 Suppl 3:81-84. [PMID: 23295696 DOI: 10.1159/000342611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
185 Kapel N, Thomas M, Corcos O, Mayeur C, Barbot-Trystram L, Bouhnik Y, Joly F. Practical implementation of faecal transplantation. Clin Microbiol Infect 2014;20:1098-105. [PMID: 25273614 DOI: 10.1111/1469-0691.12796] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
186 Chaparro-Rojas F, Mullane KM. Emerging therapies for Clostridium difficile infection - focus on fidaxomicin. Infect Drug Resist. 2013;6:41-53. [PMID: 23843696 DOI: 10.2147/idr.s24434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
187 Goodman-Davis R, Figurska M, Cywinska A. Gut Microbiota Manipulation in Foals-Naturopathic Diarrhea Management, or Unsubstantiated Folly? Pathogens 2021;10:1137. [PMID: 34578169 DOI: 10.3390/pathogens10091137] [Reference Citation Analysis]
188 Liu Y, Liu Y, Du Z, Zhang L, Chen J, Shen Z, Liu Q, Qin J, Lv H, Wang H, He L, Liu J, Huang Q, Sun Y, Otto M, Li M. Skin microbiota analysis-inspired development of novel anti-infectives. Microbiome 2020;8:85. [PMID: 32503672 DOI: 10.1186/s40168-020-00866-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
189 Khor B, Snow M, Herrman E, Ray N, Mansukhani K, Patel KA, Said-Al-Naief N, Maier T, Machida CA. Interconnections Between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance Between Systemic Health and Disease. Microorganisms 2021;9:496. [PMID: 33652903 DOI: 10.3390/microorganisms9030496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
190 Aron-wisnewsky J, Clément K, Nieuwdorp M. Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes? Curr Diab Rep 2019;19. [DOI: 10.1007/s11892-019-1180-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
191 Mullen KR, Yasuda K, Divers TJ, Weese JS. Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions. Equine Vet Educ 2018;30:151-60. [PMID: 32313396 DOI: 10.1111/eve.12559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
192 Brumbaugh DE, De Zoeten EF, Pyo-Twist A, Fidanza S, Hughes S, Dolan SA, Child J, Dominguez SR. An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive. J Pediatr 2018;194:123-127.e1. [PMID: 29198534 DOI: 10.1016/j.jpeds.2017.10.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
193 Fareed S, Sarode N, Stewart FJ, Malik A, Laghaie E, Khizer S, Yan F, Pratte Z, Lewis J, Immergluck LC. Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children. PeerJ 2018;6:e4663. [PMID: 29868248 DOI: 10.7717/peerj.4663] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
194 Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW, Tan B, Wang XY. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol 2018; 24(1): 5-14 [PMID: 29358877 DOI: 10.3748/wjg.v24.i1.5] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 116] [Article Influence: 36.3] [Reference Citation Analysis]
195 Wen HZ, Hao WW, Liu YT, Shao LJ. Fecal microbiota transplantation for inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(10): 1545-1551 [DOI: 10.11569/wcjd.v24.i10.1545] [Reference Citation Analysis]
196 Belizário JE, Faintuch J. Microbiome and Gut Dysbiosis. Exp Suppl 2018;109:459-76. [PMID: 30535609 DOI: 10.1007/978-3-319-74932-7_13] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
197 Collins SM, Kassam Z, Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013;16:240-245. [PMID: 23845749 DOI: 10.1016/j.mib.2013.06.004] [Cited by in Crossref: 121] [Cited by in F6Publishing: 112] [Article Influence: 13.4] [Reference Citation Analysis]
198 Paramsothy S, Borody TJ, Lin E, Finlayson S, Walsh AJ, Samuel D, van den Bogaerde J, Leong RWL, Connor S, Ng W, Mitchell HM, Kaakoush N, Kamm MA. Donor Recruitment for Fecal Microbiota Transplantation: . Inflammatory Bowel Diseases 2015;21:1600-6. [DOI: 10.1097/mib.0000000000000405] [Cited by in Crossref: 78] [Cited by in F6Publishing: 35] [Article Influence: 11.1] [Reference Citation Analysis]
199 Bojanova DP, Bordenstein SR. Fecal Transplants: What Is Being Transferred? PLoS Biol 2016;14:e1002503. [PMID: 27404502 DOI: 10.1371/journal.pbio.1002503] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 14.8] [Reference Citation Analysis]
200 Moelling K, Broecker F. Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases. Bacteriophage 2016;6:e1251380. [PMID: 28090385 DOI: 10.1080/21597081.2016.1251380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
201 Falcone M, Venditti M, Sanguinetti M, Posteraro B. Management of candidemia in patients with Clostridium difficile infection. Expert Rev Anti Infect Ther 2016;14:679-85. [PMID: 27254270 DOI: 10.1080/14787210.2016.1197118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
202 Taylor KN, Mchale MT, Saenz CC, Plaxe SC. Diagnosis and treatment of Clostridium difficile (C. diff) colitis: Review of the literature and a perspective in gynecologic oncology. Gynecologic Oncology 2017;144:428-37. [DOI: 10.1016/j.ygyno.2016.11.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
203 Somineni HK, Kugathasan S. The Microbiome in Patients With Inflammatory Diseases. Clin Gastroenterol Hepatol 2019;17:243-55. [PMID: 30196163 DOI: 10.1016/j.cgh.2018.08.078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
204 Terveer EM, van Beurden YH, Goorhuis A, Seegers JFML, Bauer MP, van Nood E, Dijkgraaf MGW, Mulder CJJ, Vandenbroucke-Grauls CMJE, Verspaget HW, Keller JJ, Kuijper EJ. How to: Establish and run a stool bank. Clin Microbiol Infect. 2017;23:924-930. [PMID: 28529025 DOI: 10.1016/j.cmi.2017.05.015] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 16.2] [Reference Citation Analysis]
205 Evrensel A, Tarhan KN. Emerging role of Gut-microbiota-brain axis in depression and therapeutic implication. Prog Neuropsychopharmacol Biol Psychiatry 2021;106:110138. [PMID: 33075447 DOI: 10.1016/j.pnpbp.2020.110138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
206 Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol. 2014;306:G310-G319. [PMID: 24284963 DOI: 10.1152/ajpgi.00282] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
207 Mamo G. Anaerobes as Sources of Bioactive Compounds and Health Promoting Tools. Adv Biochem Eng Biotechnol 2016;156:433-64. [PMID: 27432247 DOI: 10.1007/10_2016_6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
208 Schierová D, Březina J, Mrázek J, Fliegerová KO, Kvasnová S, Bajer L, Drastich P. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. Cells 2020;9:E2283. [PMID: 33066233 DOI: 10.3390/cells9102283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
209 Rajilić-Stojanović M. Function of the microbiota. Best Pract Res Clin Gastroenterol 2013;27:5-16. [PMID: 23768548 DOI: 10.1016/j.bpg.2013.03.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
210 Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, Wang BM. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol 2015; 21(1): 102-111 [PMID: 25574083 DOI: 10.3748/wjg.v21.i1.102] [Cited by in CrossRef: 125] [Cited by in F6Publishing: 104] [Article Influence: 17.9] [Reference Citation Analysis]
211 Borali E, De Giacomo C. Clostridium Difficile Infection in Children: A Review. Journal of Pediatric Gastroenterology & Nutrition 2016;63:e130-40. [DOI: 10.1097/mpg.0000000000001264] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
212 de Vos WM. Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes. Microb Biotechnol. 2013;6:316-325. [PMID: 23574632 DOI: 10.1111/1751-7915.12047] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
213 Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 2013;6:295-308. [PMID: 23814609 DOI: 10.1177/1756283x13482996] [Cited by in Crossref: 389] [Cited by in F6Publishing: 187] [Article Influence: 43.2] [Reference Citation Analysis]
214 Aroniadis OC, Drossman DA, Simrén M. A Perspective on Brain–Gut Communication: The American Gastroenterology Association and American Psychosomatic Society Joint Symposium on Brain–Gut Interactions and the Intestinal Microenvironment. Psychosom Med 2017;79:847-56. [DOI: 10.1097/psy.0000000000000431] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 4.2] [Reference Citation Analysis]
215 Kopper JJ, Alexander TL, Kogan CJ, Berreta AR, Burbick CR. In Vitro Evaluation of the Effect of Storage at -20°C and Proximal Gastrointestinal Conditions on Viability of Equine Fecal Microbiota Transplant. J Equine Vet Sci 2021;98:103360. [PMID: 33663713 DOI: 10.1016/j.jevs.2020.103360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
216 Williamson ED. Life sciences today and tomorrow: emerging biotechnologies. Crit Rev Biotechnol 2017;37:553-65. [PMID: 27373876 DOI: 10.1080/07388551.2016.1201455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
217 Nyholm L, Koziol A, Marcos S, Botnen AB, Aizpurua O, Gopalakrishnan S, Limborg MT, Gilbert MTP, Alberdi A. Holo-Omics: Integrated Host-Microbiota Multi-omics for Basic and Applied Biological Research. iScience 2020;23:101414. [PMID: 32777774 DOI: 10.1016/j.isci.2020.101414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
218 Markle JG, Frank DN, Adeli K, von Bergen M, Danska JS. Microbiome manipulation modifies sex-specific risk for autoimmunity. Gut Microbes. 2014;5:485-493. [PMID: 25007153 DOI: 10.4161/gmic.29795] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
219 Lv Z, Peng G, Liu W, Xu H, Su J. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. Antimicrob Agents Chemother 2015;59:3726-35. [PMID: 25824219 DOI: 10.1128/AAC.04794-14] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
220 Aroniadis OC, Brandt LJ, Greenberg A, Borody T, Kelly CR, Mellow M, Surawicz C, Cagle L, Neshatian L, Stollman N. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience. J Clin Gastroenterol. 2015;Epub ahead of print. [PMID: 26125460 DOI: 10.1097/mcg.0000000000000374] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
221 Ali H, Khurana S, Ma W, Peng Y, Jiang ZD, DuPont H, Zhang HC, Thomas AS, Okhuysen P, Wang Y. Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients. J Cancer 2021;12:6498-506. [PMID: 34659541 DOI: 10.7150/jca.59251] [Reference Citation Analysis]
222 Lewis SS, Anderson DJ. Treatment of Clostridium difficile infection: recent trial results. Clin Investig (Lond) 2013;3:875-86. [PMID: 25525499 DOI: 10.4155/cli.13.72] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
223 Vincent C, Manges AR. Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection. Antibiotics (Basel) 2015;4:230-53. [PMID: 27025623 DOI: 10.3390/antibiotics4030230] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
224 Gupta S, Bram EE, Weiss R. Genetically programmable pathogen sense and destroy. ACS Synth Biol 2013;2:715-23. [PMID: 23763381 DOI: 10.1021/sb4000417] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
225 Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012;489:220-30. [PMID: 22972295 DOI: 10.1038/nature11550] [Cited by in Crossref: 2557] [Cited by in F6Publishing: 2258] [Article Influence: 255.7] [Reference Citation Analysis]
226 Wang J, Kuo C, Kuo F, Wang Y, Hsu W, Yu F, Hu H, Hsu P, Wang J, Wu D. Fecal microbiota transplantation: Review and update. Journal of the Formosan Medical Association 2019;118:S23-31. [DOI: 10.1016/j.jfma.2018.08.011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
227 O'Horo JC, Jindai K, Kunzer B, Safdar N. Treatment of recurrent Clostridium difficile infection: a systematic review. Infection 2014;42:43-59. [PMID: 23839210 DOI: 10.1007/s15010-013-0496-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
228 Bui TPN, de Vos WM. Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases. Best Pract Res Clin Endocrinol Metab 2021;35:101504. [PMID: 33785319 DOI: 10.1016/j.beem.2021.101504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Chaudhuri A, Goddard EA, Green M, Ardura MI. Diarrhea in the pediatric solid organ transplantation recipient: A multidisciplinary approach to diagnosis and management. Pediatr Transplant 2021;25:e13886. [PMID: 33142366 DOI: 10.1111/petr.13886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
230 Mamo Y, Woodworth MH, Wang T, Dhere T, Kraft CS. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection. Clin Infect Dis 2018;66:1705-11. [PMID: 29272401 DOI: 10.1093/cid/cix1097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
231 Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol 2015;6:1050. [PMID: 26500616 DOI: 10.3389/fmicb.2015.01050] [Cited by in Crossref: 144] [Cited by in F6Publishing: 122] [Article Influence: 20.6] [Reference Citation Analysis]
232 Orenstein R, King K, Patron RL, DiBaise JK, Etzioni D. Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy. Clin Infect Dis 2018;66:299-300. [PMID: 29020255 DOI: 10.1093/cid/cix736] [Reference Citation Analysis]
233 Asempa TE, Nicolau DP. Clostridium difficile infection in the elderly: an update on management. Clin Interv Aging 2017;12:1799-809. [PMID: 29123385 DOI: 10.2147/CIA.S149089] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 7.6] [Reference Citation Analysis]
234 Kaiser AM, Hogen R, Bordeianou L, Alavi K, Wise PE, Sudan R; On behalf of the CME Committee of the SSAT. Clostridium Difficile Infection from a Surgical Perspective. J Gastrointest Surg 2015;19:1363-77. [DOI: 10.1007/s11605-015-2785-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
235 Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS; PUNCH CD Investigators. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study. Clin Infect Dis. 2016;62:596-602. [PMID: 26565008 DOI: 10.1093/cid/civ938] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 12.0] [Reference Citation Analysis]
236 Wilcox MH. Progress with a difficult infection. The Lancet Infectious Diseases 2012;12:256-7. [DOI: 10.1016/s1473-3099(12)70013-0] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
237 Gerardo NM, Hoang KL, Stoy KS. Evolution of animal immunity in the light of beneficial symbioses. Philos Trans R Soc Lond B Biol Sci 2020;375:20190601. [PMID: 32772666 DOI: 10.1098/rstb.2019.0601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
238 Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol. 2012;5:403-420. [PMID: 23152734 DOI: 10.1177/1756283x12453637] [Cited by in Crossref: 119] [Cited by in F6Publishing: 60] [Article Influence: 11.9] [Reference Citation Analysis]
239 Zainah H, Hassan M, Shiekh-Sroujieh L, Hassan S, Alangaden G, Ramesh M. Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci. 2015;60:181-185. [PMID: 25052150 DOI: 10.1007/s10620-014-3296-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
240 Stumpf R, Gomez A, Amato K, Yeoman C, Polk J, Wilson B, Nelson K, White B, Leigh S. Microbiomes, metagenomics, and primate conservation: New strategies, tools, and applications. Biological Conservation 2016;199:56-66. [DOI: 10.1016/j.biocon.2016.03.035] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
241 Bono-lunn D, Villeneuve C, Abdulhay NJ, Harker M, Parker W. Policy and regulations in light of the human body as a ‘superorganism’ containing multiple, intertwined symbiotic relationships. Clinical Research and Regulatory Affairs 2016;33:39-48. [DOI: 10.1080/10601333.2016.1210159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
242 Arora SK, Dewan P, Gupta P. Microbiome: Paediatricians' perspective. Indian J Med Res 2015;142:515-24. [PMID: 26658584 DOI: 10.4103/0971-5916.171275] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
243 Metzger SA, Hernandez LL, Suen G, Ruegg PL. Understanding the Milk Microbiota. Vet Clin North Am Food Anim Pract 2018;34:427-38. [PMID: 30316501 DOI: 10.1016/j.cvfa.2018.06.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
244 Gweon TG, Lee YJ, Kim KO, Yim SK, Soh JS, Kim SY, Park JJ, Shin SY, Lee TH, Choi CH, Cho YS, Yong D, Chung JW, Lee KJ, Lee OY, Choi MG, Choi M; Gut Microbiota and Therapy Research Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea. J Neurogastroenterol Motil 2022;28:28-42. [PMID: 34980687 DOI: 10.5056/jnm21221] [Reference Citation Analysis]
245 Marsh JW, Curry SR. Therapeutic Approaches for Clostridium difficile Infections. Current Protocols in Microbiology 2013;30. [DOI: 10.1002/9780471729259.mc09a03s30] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
246 Gupta A, Saha S, Khanna S. Therapies to modulate gut microbiota: Past, present and future. World J Gastroenterol 2020; 26(8): 777-788 [PMID: 32148376 DOI: 10.3748/wjg.v26.i8.777] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
247 Owens C, Broussard E, Surawicz C. Fecal microbiota transplantation and donor standardization. Trends Microbiol. 2013;21:443-445. [PMID: 24012274 DOI: 10.1016/j.tim.2013.07.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
248 Vaughn BP, Vatanen T, Allegretti JR, Bai A, Xavier RJ, Korzenik J, Gevers D, Ting A, Robson SC, Moss AC. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease. Inflamm Bowel Dis. 2016;22:2182-2190. [PMID: 27542133 DOI: 10.1097/mib.0000000000000893] [Cited by in Crossref: 114] [Cited by in F6Publishing: 63] [Article Influence: 28.5] [Reference Citation Analysis]
249 Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, Cassidy L, Tholey A, Fickenscher H, Seegert D, Rosenstiel P, Schreiber S. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology. 2017;152:799-811.e7. [PMID: 27866880 DOI: 10.1053/j.gastro.2016.11.010] [Cited by in Crossref: 272] [Cited by in F6Publishing: 242] [Article Influence: 45.3] [Reference Citation Analysis]
250 Stephen-victor E, Bosschem I, Haesebrouck F, Bayry J. The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them. Cellular Microbiology 2017;19:e12746. [DOI: 10.1111/cmi.12746] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
251 Evrensel A, Önen Ünsalver B, Ceylan ME. Therapeutic Potential of the Microbiome in the Treatment of Neuropsychiatric Disorders. Med Sci (Basel) 2019;7:E21. [PMID: 30709065 DOI: 10.3390/medsci7020021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
252 Costello SP, Conlon MA, Vuaran MS, Roberts-Thomson IC, Andrews JM. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data. Aliment Pharmacol Ther. 2015;42:1011-1018. [PMID: 26264455 DOI: 10.1111/apt.13366] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 11.4] [Reference Citation Analysis]
253 Mullane K. Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance. Ther Adv Chronic Dis 2014;5:69-84. [PMID: 24587892 DOI: 10.1177/2040622313511285] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
254 Franzosa EA, Hsu T, Sirota-Madi A, Shafquat A, Abu-Ali G, Morgan XC, Huttenhower C. Sequencing and beyond: integrating molecular 'omics' for microbial community profiling. Nat Rev Microbiol 2015;13:360-72. [PMID: 25915636 DOI: 10.1038/nrmicro3451] [Cited by in Crossref: 344] [Cited by in F6Publishing: 292] [Article Influence: 49.1] [Reference Citation Analysis]
255 El-Matary W, Simpson R, Ricketts-Burns N. Fecal microbiota transplantation: are we opening a can of worms? Gastroenterology. 2012;143:e19; author reply e19-e19; author reply e20. [PMID: 22732575 DOI: 10.1053/j.gastro.2012.04.055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
256 Bakker GJ, Nieuwdorp M. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. Microbiol Spectr 2017;5. [PMID: 28840809 DOI: 10.1128/microbiolspec.BAD-0008-2017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
257 Lin P. The role of the intestinal microbiome in ocular inflammatory disease. Curr Opin Ophthalmol 2018;29:261-6. [PMID: 29538183 DOI: 10.1097/ICU.0000000000000465] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
258 Dennis M, Salpeter MJ, Hota S. Low awareness but positive attitudes toward fecal transplantation in Ontario physicians. Can J Infect Dis Med Microbiol 2015;26:30-2. [PMID: 25798151 DOI: 10.1155/2015/496437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
259 Costa MC, Weese JS. The equine intestinal microbiome. Anim Health Res Rev 2012;13:121-8. [PMID: 22626511 DOI: 10.1017/S1466252312000035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
260 Gundacker ND, Tamhane A, Walker JB, Morrow CD, Rodriguez JM. Comparative effectiveness of faecal microbiota transplant by route of administration. J Hosp Infect 2017;96:349-52. [PMID: 28501333 DOI: 10.1016/j.jhin.2017.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
261 Dubberke ER, Mullane KM, Gerding DN, Lee CH, Louie TJ, Guthertz H, Jones C. Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection. Open Forum Infect Dis. 2016;3:ofw133. [PMID: 27703995 DOI: 10.1093/ofid/ofw133] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
262 Seong H, Lee SK, Cheon JH, Yong DE, Koh H, Kang YK, Jeong WY, Lee WJ, Sohn Y, Cho Y, Hyun JH, Baek YJ, Kim MH, Kim JH, Ahn JY, Ku NS, Jeong SJ, Yeom JS, Cho MS, Lee JH, Kim BY, Choi JY. Fecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction. J Infect 2020;81:719-25. [PMID: 32920061 DOI: 10.1016/j.jinf.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
263 Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Infect. 2013;66:115-128. [PMID: 23103666 DOI: 10.1016/j.jinf.2012.10.019] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 8.5] [Reference Citation Analysis]
264 Elahi M, Nakayama-Imaohji H, Hashimoto M, Tada A, Yamasaki H, Nagao T, Kuwahara T. The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis. Antibiotics (Basel) 2021;10:187. [PMID: 33671889 DOI: 10.3390/antibiotics10020187] [Reference Citation Analysis]
265 Singh RP, Bashir H, Kumar R. Emerging role of microbiota in immunomodulation and cancer immunotherapy. Semin Cancer Biol 2021;70:37-52. [PMID: 32580024 DOI: 10.1016/j.semcancer.2020.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
266 Li Y, Zou Z, Bian X, Huang Y, Wang Y, Yang C, Zhao J, Xie L. Fecal microbiota transplantation research output from 2004 to 2017: a bibliometric analysis. PeerJ. 2019;7:e6411. [PMID: 30809438 DOI: 10.7717/peerj.6411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
267 Gupta S, Zhu J, McCarty TR, Pruce J, Kassam Z, Kelly C, Fischer M, Allegretti JR. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. J Gastroenterol Hepatol 2021. [PMID: 33682170 DOI: 10.1111/jgh.15483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
268 Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc. 2013;78:240-249. [PMID: 23642791 DOI: 10.1016/j.gie.2013.03.1329] [Cited by in Crossref: 141] [Cited by in F6Publishing: 117] [Article Influence: 15.7] [Reference Citation Analysis]
269 Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012;87:1106-1117. [PMID: 23127735 DOI: 10.1016/j.mayocp.2012.07.016] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 9.1] [Reference Citation Analysis]
270 Mazzawi T, Lied GA, Sangnes DA, El-Salhy M, Hov JR, Gilja OH, Hatlebakk JG, Hausken T. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLoS One 2018;13:e0194904. [PMID: 30427836 DOI: 10.1371/journal.pone.0194904] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
271 Knight CL, Surawicz CM. Clostridium difficile Infection. Medical Clinics of North America 2013;97:523-36. [DOI: 10.1016/j.mcna.2013.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
272 Rubin TA, Gessert CE, Aas J, Bakken JS. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe. 2013;19:22-26. [PMID: 23182843 DOI: 10.1016/j.anaerobe.2012.11.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 7.9] [Reference Citation Analysis]
273 Zellmer C, De Wolfe TJ, Van Hoof S, Blakney R, Safdar N. Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection. Infect Dis Ther 2016;5:155-64. [PMID: 27048199 DOI: 10.1007/s40121-016-0106-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
274 Angarone M, Ison MG. Diarrhea in solid organ transplant recipients. Curr Opin Infect Dis 2015;28:308-16. [PMID: 26098506 DOI: 10.1097/QCO.0000000000000172] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
275 Pérez-Cobas AE, Moya A, Gosalbes MJ, Latorre A. Colonization Resistance of the Gut Microbiota against Clostridium difficile. Antibiotics (Basel) 2015;4:337-57. [PMID: 27025628 DOI: 10.3390/antibiotics4030337] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
276 Seedorf H, Griffin NW, Ridaura VK, Reyes A, Cheng J, Rey FE, Smith MI, Simon GM, Scheffrahn RH, Woebken D, Spormann AM, Van Treuren W, Ursell LK, Pirrung M, Robbins-Pianka A, Cantarel BL, Lombard V, Henrissat B, Knight R, Gordon JI. Bacteria from diverse habitats colonize and compete in the mouse gut. Cell 2014;159:253-66. [PMID: 25284151 DOI: 10.1016/j.cell.2014.09.008] [Cited by in Crossref: 201] [Cited by in F6Publishing: 184] [Article Influence: 25.1] [Reference Citation Analysis]
277 Rao K, Young VB, Aronoff DM. Fecal microbiota therapy: ready for prime time? Infect Control Hosp Epidemiol 2014;35:28-30. [PMID: 24334795 DOI: 10.1086/674395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
278 López-sanromán A, Rodríguez de Santiago E, Cobo Reinoso J, del Campo Moreno R, Foruny Olcina JR, García Fernández S, García García de Paredes A, Aguilera Castro L, Ferre Aracil C, Albillos Martínez A. Resultados de la implementación de un programa multidisciplinar de trasplante de microbiota fecal por colonoscopia para el tratamiento de la infección recurrente por Clostridium difficile. Gastroenterología y Hepatología 2017;40:605-14. [DOI: 10.1016/j.gastrohep.2017.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
279 Borody TJ, Brandt LJ, Paramsothy S. Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol. 2014;30:97-105. [PMID: 24257037 DOI: 10.1097/mog.0000000000000027] [Cited by in Crossref: 78] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
280 Kumar V, Fischer M. Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond. Expert Opin Biol Ther. 2020;20:73-81. [PMID: 31690143 DOI: 10.1080/14712598.2020.1689952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
281 Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 2013;5:79-99. [PMID: 23569399 DOI: 10.2147/dhps.s28801] [Cited by in Crossref: 124] [Cited by in F6Publishing: 69] [Article Influence: 13.8] [Reference Citation Analysis]
282 Cheng YW, Fischer M. The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly. Curr Treat Options Gastroenterol 2017;15:349-62. [PMID: 28748314 DOI: 10.1007/s11938-017-0143-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
283 van Beurden YH, de Groot PF, van Nood E, Nieuwdorp M, Keller JJ, Goorhuis A. Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection. United European Gastroenterol J 2017;5:868-79. [PMID: 29026601 DOI: 10.1177/2050640616678099] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
284 Takahashi M, Ishikawa D, Sasaki T, Lu YJ, Kuwahara-Arai K, Kamei M, Shibuya T, Osada T, Hiramatsu K, Nagahara A. Faecal freezing preservation period influences colonization ability for faecal microbiota transplantation. J Appl Microbiol 2019;126:973-84. [PMID: 30489686 DOI: 10.1111/jam.14167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
285 Doh YS, Kim YS, Jung HJ, Park YI, Mo JW, Sung H, Lee KJ, Seo YK, Moon JS, Hong SW. Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study. Intest Res 2014;12:299-305. [PMID: 25374496 DOI: 10.5217/ir.2014.12.4.299] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
286 Hsu PS, Campbell DE. A bug's view of allergic airways disease. Paediatr Respir Rev 2016;19:69-74. [PMID: 27012478 DOI: 10.1016/j.prrv.2016.02.002] [Reference Citation Analysis]
287 Seufferlein T, Kleger A, Nitschmann S. [Recurrent Clostridium difficile infection. Treatment with duodenal infusion of donor feces]. Internist (Berl) 2014;55:455-9. [PMID: 24647687 DOI: 10.1007/s00108-014-3483-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
288 Paasché S. Fecal microbiota transplantation: an innovative approach to treating Clostridium difficile disease. JAAPA 2013;26:46-9. [PMID: 24049940 DOI: 10.1097/01.jaa.0000432570.98817.16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
289 Lübbert C, Salzberger B, Mössner J. [Fecal microbiota transplantation]. Internist (Berl) 2017;58:456-68. [PMID: 28235986 DOI: 10.1007/s00108-017-0203-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
290 Singh R, van Nood E, Nieuwdorp M, van Dam B, ten Berge IJ, Geerlings SE, Bemelman FJ. Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease. Clin Microbiol Infect. 2014;20:O977-O978. [PMID: 24845223 DOI: 10.1111/1469-0691.12683] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 9.6] [Reference Citation Analysis]
291 Omar A, Wright JB, Schultz G, Burrell R, Nadworny P. Microbial Biofilms and Chronic Wounds. Microorganisms 2017;5:E9. [PMID: 28272369 DOI: 10.3390/microorganisms5010009] [Cited by in Crossref: 123] [Cited by in F6Publishing: 82] [Article Influence: 24.6] [Reference Citation Analysis]
292 Mihaescu A, Augustine AM, Khokhar HT, Zafran M, Masood SSME, Gilca-Blanariu GE, Covic A, Nistor I. Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review. Biomed Res Int 2021;2021:5466656. [PMID: 34557546 DOI: 10.1155/2021/5466656] [Reference Citation Analysis]
293 Cavuoto KM, Banerjee S, Galor A. Relationship between the microbiome and ocular health. Ocul Surf 2019;17:384-92. [PMID: 31125783 DOI: 10.1016/j.jtos.2019.05.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
294 Keen EC. Felix d’Herelle and our microbial future. Future Microbiology 2012;7:1337-9. [DOI: 10.2217/fmb.12.115] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
295 Bakken JS. Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations. Microb Ecol Health Dis 2015;26:27657. [PMID: 26031677 DOI: 10.3402/mehd.v26.27657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
296 Pereira GQ, Gomes LA, Santos IS, Alfieri AF, Weese JS, Costa MC. Fecal microbiota transplantation in puppies with canine parvovirus infection. J Vet Intern Med 2018;32:707-11. [PMID: 29460302 DOI: 10.1111/jvim.15072] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
297 Bassetti M, Villa G, Pecori D, Arzese A, Wilcox M. Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Rev Anti Infect Ther 2012;10:1405-23. [PMID: 23253319 DOI: 10.1586/eri.12.135] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
298 Vujkovic-Cvijin I, Rutishauser RL, Pao M, Hunt PW, Lynch SV, McCune JM, Somsouk M. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. Gut Microbes 2017;8:440-50. [PMID: 28541799 DOI: 10.1080/19490976.2017.1334034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
299 Laffin M, Millan B, Madsen KL. Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms. Gut Microbes 2017;8:221-4. [PMID: 28059612 DOI: 10.1080/19490976.2016.1278105] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
300 Rao K, Safdar N. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J Hosp Med 2016;11:56-61. [PMID: 26344412 DOI: 10.1002/jhm.2449] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
301 Messias BA, Franchi BF, Pontes PH, Barbosa DÁDAM, Viana CAS. Fecal microbiota transplantation in the treatment of Clostridium difficile infection: state of the art and literature review. Rev Col Bras Cir 2018;45. [DOI: 10.1590/0100-6991e-20181609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
302 Nicholson MR, Osgood CL, Acra SA, Edwards KM. Clostridium difficile infection in the pediatric transplant patient. Pediatr Transplant 2015;19:792-8. [PMID: 26403484 DOI: 10.1111/petr.12578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
303 Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc 2015;63:776-81. [PMID: 25851728 DOI: 10.1111/jgs.13310] [Cited by in Crossref: 138] [Cited by in F6Publishing: 114] [Article Influence: 19.7] [Reference Citation Analysis]
304 Nagy GG, Várvölgyi C, Balogh Z, Orosi P, Paragh G. [Detailed methodological recommendations for the treatment of Clostridium difficile-associated diarrhea with faecal transplantation]. Orv Hetil 2013;154:10-9. [PMID: 23274229 DOI: 10.1556/OH.2013.29514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
305 Kronman MP, Nielson HJ, Adler AL, Giefer MJ, Wahbeh G, Singh N, Zerr DM, Suskind DL. Fecal microbiota transplantation via nasogastric tube for recurrent clostridium difficile infection in pediatric patients. J Pediatr Gastroenterol Nutr. 2015;60:23-26. [PMID: 25162365 DOI: 10.1097/mpg.0000000000000545] [Cited by in Crossref: 49] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
306 Sbahi H, Di Palma JA. Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol 2016;3:e000087. [PMID: 27239328 DOI: 10.1136/bmjgast-2016-000087] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
307 Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol. 2016;9:229-239. [PMID: 26929784 DOI: 10.1177/1756283x15607414] [Cited by in Crossref: 142] [Cited by in F6Publishing: 70] [Article Influence: 23.7] [Reference Citation Analysis]
308 Holmes E, Wijeyesekera A, Taylor-Robinson SD, Nicholson JK. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2015;12:458-71. [PMID: 26194948 DOI: 10.1038/nrgastro.2015.114] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
309 Huang L, Zhu Q, Qu X, Qin H. Microbial treatment in chronic constipation. Sci China Life Sci 2018;61:744-52. [PMID: 29388040 DOI: 10.1007/s11427-017-9220-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
310 Ironstone P. Me, my self, and the multitude: Microbiopolitics of the human microbiome. European Journal of Social Theory 2018;22:325-41. [DOI: 10.1177/1368431018811330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
311 Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta S, Fricke WF. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One. 2013;8:e81330. [PMID: 24303043 DOI: 10.1371/journal.pone.0081330] [Cited by in Crossref: 125] [Cited by in F6Publishing: 107] [Article Influence: 13.9] [Reference Citation Analysis]
312 Upton DA; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Clostridium difficile in paediatric populations. Paediatrics & Child Health 2014;19:43-8. [DOI: 10.1093/pch/19.1.43] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
313 Hu J, Chen L, Tang Y, Xie C, Xu B, Shi M, Zheng W, Zhou S, Wang X, Liu L, Yan Y, Yang T, Niu Y, Hou Q, Xu X, Yan X. Standardized Preparation for Fecal Microbiota Transplantation in Pigs. Front Microbiol 2018;9:1328. [PMID: 29971061 DOI: 10.3389/fmicb.2018.01328] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
314 Brubaker L, Wolfe AJ. The Female Urinary Microbiota/Microbiome: Clinical and Research Implications. Rambam Maimonides Med J 2017;8. [PMID: 28467757 DOI: 10.5041/RMMJ.10292] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
315 Schneider KM, Wirtz TH, Kroy D, Albers S, Neumann UP, Strowig T, Sellge G, Trautwein C. Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation. Case Rep Gastroenterol 2018;12:76-84. [PMID: 29606940 DOI: 10.1159/000481937] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
316 Mulcahy-O'Grady H, Workentine ML. The Challenge and Potential of Metagenomics in the Clinic. Front Immunol 2016;7:29. [PMID: 26870044 DOI: 10.3389/fimmu.2016.00029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
317 Vasilescu I, Chifiriuc M, Pircalabioru GG, Filip R, Bolocan A, Lazăr V, Diţu L, Bleotu C. Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults. Front Microbiol 2022;12:651081. [DOI: 10.3389/fmicb.2021.651081] [Reference Citation Analysis]
318 Tavoukjian V. Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis. J Hosp Infect 2019;102:174-88. [PMID: 30926290 DOI: 10.1016/j.jhin.2019.03.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
319 Lemon KP, Armitage GC, Relman DA, Fischbach MA. Microbiota-targeted therapies: an ecological perspective. Sci Transl Med 2012;4:137rv5. [PMID: 22674555 DOI: 10.1126/scitranslmed.3004183] [Cited by in Crossref: 163] [Cited by in F6Publishing: 147] [Article Influence: 16.3] [Reference Citation Analysis]
320 Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108:500-508. [PMID: 23511459 DOI: 10.1038/ajg.2013.59] [Cited by in Crossref: 553] [Cited by in F6Publishing: 479] [Article Influence: 61.4] [Reference Citation Analysis]
321 Shin JH, Chaplin AS, Hays RA, Kolling GL, Vance S, Guerrant RL, Archbald-Pannone L, Warren CA. Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis. J Clin Med 2019;8:E1036. [PMID: 31315214 DOI: 10.3390/jcm8071036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
322 Debast SB, Bauer MP, Kuijper EJ;  European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20 Suppl 2:1-26. [PMID: 24118601 DOI: 10.1111/1469-0691.12418] [Cited by in Crossref: 692] [Cited by in F6Publishing: 607] [Article Influence: 86.5] [Reference Citation Analysis]
323 Wei Y, Gong J, Zhu W, Tian H, Ding C, Gu L, Li N, Li J. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol 2016;16:255. [PMID: 27809778 DOI: 10.1186/s12866-016-0869-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
324 Bringiotti R, Ierardi E, Lovero R, Losurdo G, Leo AD, Principi M. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol 2014; 5(4): 550-559 [PMID: 25400998 DOI: 10.4291/wjgp.v5.i4.550] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
325 Khanna S, Pardi DS. Clostridium difficile infection: management strategies for a difficult disease. Therap Adv Gastroenterol 2014;7:72-86. [PMID: 24587820 DOI: 10.1177/1756283X13508519] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
326 Radšel A, Andlovic A, Neubauer D, Osredkar D. Infant botulism: First two confirmed cases in Slovenia and literature review. European Journal of Paediatric Neurology 2013;17:651-6. [DOI: 10.1016/j.ejpn.2013.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
327 Kurečič M, Rijavec T, Hribernik S, Lapanje A, Kleinschek KS, Maver U. Novel electrospun fibers with incorporated commensal bacteria for potential preventive treatment of the diabetic foot. Nanomedicine (Lond) 2018;13:1583-94. [PMID: 30028247 DOI: 10.2217/nnm-2018-0014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
328 Sha S, Liang J, Chen M, Xu B, Liang C, Wei N, Wu K. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther. 2014;39:1003-1032. [PMID: 24641570 DOI: 10.1111/apt.12699] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
329 Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50:495-507. [PMID: 25808229 DOI: 10.1007/s00535-015-1064-1] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 17.7] [Reference Citation Analysis]
330 Chuong KH, O'Doherty KC, Secko DM. Media Discourse on the Social Acceptability of Fecal Transplants. Qual Health Res 2015;25:1359-71. [PMID: 25595150 DOI: 10.1177/1049732314568199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
331 Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS; Blood and Marrow Transplant Clinical Trials Network. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. Biol Blood Marrow Transplant 2018;24:1322-40. [PMID: 29471034 DOI: 10.1016/j.bbmt.2018.02.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
332 Keller JM, Surawicz CM. Clostridium difficile infection in the elderly. Clin Geriatr Med 2014;30:79-93. [PMID: 24267604 DOI: 10.1016/j.cger.2013.10.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
333 Basson AR, Zhou Y, Seo B, Rodriguez-Palacios A, Cominelli F. Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease. Transl Res 2020;226:1-11. [PMID: 32585148 DOI: 10.1016/j.trsl.2020.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
334 Albenberg L, Kelsen J. Advances in Gut Microbiome Research and Relevance to Pediatric Diseases. The Journal of Pediatrics 2016;178:16-23. [DOI: 10.1016/j.jpeds.2016.08.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
335 Baunwall SMD, Lee MM, Eriksen MK, Mullish BH, Marchesi JR, Dahlerup JF, Hvas CL. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine 2020;29-30:100642. [PMID: 33437951 DOI: 10.1016/j.eclinm.2020.100642] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
336 Kassam Z, Lee CH, Hunt RH. Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges. Clinics in Laboratory Medicine 2014;34:787-98. [DOI: 10.1016/j.cll.2014.08.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
337 Avery L, Hasan M. Fecal Bacteriotherapy for Clostridium difficile Infections — Its Time Has Come. Clinical Microbiology Newsletter 2013;35:119-24. [DOI: 10.1016/j.clinmicnews.2013.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
338 Baquero F, Nombela C. The microbiome as a human organ. Clin Microbiol Infect 2012;18 Suppl 4:2-4. [PMID: 22647038 DOI: 10.1111/j.1469-0691.2012.03916.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 132] [Article Influence: 15.7] [Reference Citation Analysis]
339 Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29:79-84. [PMID: 23041678 DOI: 10.1097/mog.0b013e32835a4b3e] [Cited by in Crossref: 201] [Cited by in F6Publishing: 112] [Article Influence: 22.3] [Reference Citation Analysis]
340 Piper HG. Intestinal microbiota in short bowel syndrome. Semin Pediatr Surg 2018;27:223-8. [PMID: 30342596 DOI: 10.1053/j.sempedsurg.2018.07.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
341 Gollwitzer ES, Marsland BJ. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy. Pharmacol Ther. 2014;141:32-39. [PMID: 23969226 DOI: 10.1016/j.pharmthera.2013.08.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 6.2] [Reference Citation Analysis]
342 Gu S, Chen Y, Zhang X, Lu H, Lv T, Shen P, Lv L, Zheng B, Jiang X, Li L. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes and Infection 2016;18:30-8. [DOI: 10.1016/j.micinf.2015.09.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
343 Church DL. Selected Topics in Anaerobic Bacteriology. Microbiol Spectr 2016;4. [PMID: 27726792 DOI: 10.1128/microbiolspec.DMIH2-0015-2015] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
344 McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66:e1-e48. [PMID: 29462280 DOI: 10.1093/cid/cix1085] [Cited by in Crossref: 718] [Cited by in F6Publishing: 613] [Article Influence: 239.3] [Reference Citation Analysis]
345 Dubberke ER, Lee CH, Orenstein R, Khanna S, Hecht G, Gerding DN. Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection. Clin Infect Dis 2018;67:1198-204. [PMID: 29617739 DOI: 10.1093/cid/ciy259] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
346 Lin P. Importance of the intestinal microbiota in ocular inflammatory diseases: A review. Clin Exp Ophthalmol 2019;47:418-22. [PMID: 30834680 DOI: 10.1111/ceo.13493] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
347 Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos KH, Croft N, Navas-López VM, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:292-310. [PMID: 30044358 DOI: 10.1097/MPG.0000000000002036] [Cited by in Crossref: 64] [Cited by in F6Publishing: 21] [Article Influence: 21.3] [Reference Citation Analysis]
348 Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med. 2014;9:365-373. [PMID: 24664520 DOI: 10.1007/s11739-014-1069-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
349 Cammarota G, Ianiro G, Gasbarrini A, Masucci L, Sanguinetti M. Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy. Digestive and Liver Disease 2014;46:475. [DOI: 10.1016/j.dld.2013.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
350 Chilton C, Pickering D, Freeman J. Microbiologic factors affecting Clostridium difficile recurrence. Clinical Microbiology and Infection 2018;24:476-82. [DOI: 10.1016/j.cmi.2017.11.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
351 Anand R, Song Y, Garg S, Girotra M, Sinha A, Sivaraman A, Phillips L, Dutta SK. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes. Dig Dis Sci 2017;62:1002-8. [DOI: 10.1007/s10620-017-4449-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
352 Lorimer J. Parasites, ghosts and mutualists: a relational geography of microbes for global health. Trans Inst Br Geogr 2017;42:544-58. [DOI: 10.1111/tran.12189] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 6.2] [Reference Citation Analysis]
353 Madan R, Petri WA Jr. Immune responses to Clostridium difficile infection. Trends Mol Med 2012;18:658-66. [PMID: 23084763 DOI: 10.1016/j.molmed.2012.09.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
354 Sierocinski P, Soria Pascual J, Padfield D, Salter M, Buckling A. The impact of propagule pressure on whole community invasions in biomethane-producing communities. iScience 2021;24:102659. [PMID: 34151242 DOI: 10.1016/j.isci.2021.102659] [Reference Citation Analysis]
355 Nwokoro E, Leach R, Årdal C, Baraldi E, Ryan K, Plahte J. An assessment of the future impact of alternative technologies on antibiotics markets. J Pharm Policy Pract 2016;9:34. [PMID: 27800166 DOI: 10.1186/s40545-016-0085-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
356 Brace C, Gloor GB, Ropeleski M, Allen-vercoe E, Petrof EO. Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations. J Crohns Colitis 2014;8:1133-7. [DOI: 10.1016/j.crohns.2014.01.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
357 Britton RA, Young VB. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol 2012;20:313-9. [PMID: 22595318 DOI: 10.1016/j.tim.2012.04.001] [Cited by in Crossref: 166] [Cited by in F6Publishing: 149] [Article Influence: 16.6] [Reference Citation Analysis]
358 Łaniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol 2020;17:232-50. [PMID: 32071434 DOI: 10.1038/s41585-020-0286-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
359 Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013;108:1620-1630. [PMID: 24060759 DOI: 10.1038/ajg.2013.257] [Cited by in Crossref: 234] [Cited by in F6Publishing: 208] [Article Influence: 26.0] [Reference Citation Analysis]
360 Valiquette L, Laupland KB. Something old, something new, something borrowed... Can J Infect Dis Med Microbiol 2013;24:63-4. [PMID: 24421800 DOI: 10.1155/2013/514130] [Reference Citation Analysis]
361 Borody TJ, Brandt LJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection. Expert Rev Anti Infect Ther. 2013;11:447-449. [PMID: 23627849 DOI: 10.1586/eri.13.26] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
362 Kaiser L, Surawicz CM. Infectious causes of chronic diarrhoea. Best Pract Res Clin Gastroenterol. 2012;26:563-571. [PMID: 23384802 DOI: 10.1016/j.bpg.2012.11.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
363 Lee STM, Kahn SA, Delmont TO, Shaiber A, Esen ÖC, Hubert NA, Morrison HG, Antonopoulos DA, Rubin DT, Eren AM. Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome 2017;5:50. [PMID: 28473000 DOI: 10.1186/s40168-017-0270-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 8.4] [Reference Citation Analysis]
364 Goudarzi M, Seyedjavadi SS, Goudarzi H, Mehdizadeh Aghdam E, Nazeri S. Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica (Cairo) 2014;2014:916826. [PMID: 24991448 DOI: 10.1155/2014/916826] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
365 Baunwall SMD, Dahlerup JF, Engberg JH, Erikstrup C, Helms M, Juel MA, Kjeldsen J, Nielsen HL, Nilsson AC, Rode AA, Vinter-Jensen L, Hvas CL. Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT). Scand J Gastroenterol 2021;56:1056-77. [PMID: 34261379 DOI: 10.1080/00365521.2021.1922749] [Reference Citation Analysis]
366 Brandt LJ. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 2013;108:177-185. [PMID: 23318479 DOI: 10.1038/ajg.2012.450] [Cited by in Crossref: 119] [Cited by in F6Publishing: 99] [Article Influence: 13.2] [Reference Citation Analysis]
367 Liu Y, Alnababtah K, Cook S, Yu Y. Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review. Therap Adv Gastroenterol 2021;14:17562848211042679. [PMID: 34567271 DOI: 10.1177/17562848211042679] [Reference Citation Analysis]
368 Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GA, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P. WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg 2015;10:38. [PMID: 26300956 DOI: 10.1186/s13017-015-0033-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
369 Hefazi M, Patnaik MM, Hogan WJ, Litzow MR, Pardi DS, Khanna S. Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series. Mayo Clin Proc. 2017;92:1617-1624. [PMID: 29101931 DOI: 10.1016/j.mayocp.2017.08.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
370 Cammack KM, Austin KJ, Lamberson WR, Conant GC, Cunningham HC. RUMINANT NUTRITION SYMPOSIUM: Tiny but mighty: the role of the rumen microbes in livestock production. J Anim Sci 2018;96:752-70. [PMID: 29385535 DOI: 10.1093/jas/skx053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
371 Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?Best Pract Res Clin Gastroenterol. 2013;27:127-137. [PMID: 23768558 DOI: 10.1016/j.bpg.2013.03.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
372 Cheng Y, Fischer M. Clinical management of severe, fulminant, and refractory Clostridioides difficile infection. Expert Review of Anti-infective Therapy 2020;18:323-33. [DOI: 10.1080/14787210.2020.1730814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
373 Lawley TD, Young VB. Murine models to study Clostridium difficile infection and transmission. Anaerobe 2013;24:94-7. [PMID: 24076318 DOI: 10.1016/j.anaerobe.2013.09.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
374 Jeon YD, Hong N, Kim JH, Park SH, Kim SB, Song IJ, Ann HW, Ahn JY, Kim SB, Ku NS, Lee K, Yong D, Kim JM, Choi JY. Fecal Transplantation using a Nasoenteric Tube during an Initial Episode of Severe Clostridium difficile Infection. Infect Chemother 2016;48:31-5. [PMID: 27104013 DOI: 10.3947/ic.2016.48.1.31] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
375 Winston JA, Rivera AJ, Cai J, Thanissery R, Montgomery SA, Patterson AD, Theriot CM. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids. Infect Immun 2020;88:e00045-20. [PMID: 32205405 DOI: 10.1128/IAI.00045-20] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
376 Villeneuve C, Kou HH, Eckermann H, Palkar A, Anderson LG, Mckenney EA, Bollinger RR, Parker W. Evolution of the hygiene hypothesis into biota alteration theory: what are the paradigms and where are the clinical applications? Microbes and Infection 2018;20:147-55. [DOI: 10.1016/j.micinf.2017.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
377 Rode AA, Bytzer P, Pedersen OB, Engberg J. Establishing a donor stool bank for faecal microbiota transplantation: methods and feasibility. Eur J Clin Microbiol Infect Dis 2019;38:1837-47. [PMID: 31273647 DOI: 10.1007/s10096-019-03615-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
378 Chen CC, Chiu CH. Current and future applications of fecal microbiota transplantation for children. Biomed J 2021:S2319-4170(21)00153-0. [PMID: 34781002 DOI: 10.1016/j.bj.2021.11.004] [Reference Citation Analysis]
379 Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 2016; 22(7): 2219-2241 [PMID: 26900286 DOI: 10.3748/wjg.v22.i7.2219] [Cited by in CrossRef: 155] [Cited by in F6Publishing: 120] [Article Influence: 25.8] [Reference Citation Analysis]
380 Schmitz S, Suchodolski J. Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence? Vet Med Sci 2016;2:71-94. [PMID: 29067182 DOI: 10.1002/vms3.17] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
381 Furuya-Kanamori L, Doi SA, Paterson DL, Helms SK, Yakob L, McKenzie SJ, Garborg K, Emanuelsson F, Stollman N, Kronman MP, Clark J, Huber CA, Riley TV, Clements AC. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies. J Clin Gastroenterol. 2017;51:145-150. [PMID: 26974758 DOI: 10.1097/mcg.0000000000000511] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
382 Brandt LJ. Fecal Microbiota Transplant: Respice, Adspice, Prospice. J Clin Gastroenterol. 2015;49 Suppl 1:S65-S68. [PMID: 26447968 DOI: 10.1097/mcg.0000000000000346] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
383 Seril DN, Shen B. Clostridium difficile Infection in the Postcolectomy Patient: . Inflammatory Bowel Diseases 2014;20:2450-69. [DOI: 10.1097/mib.0000000000000164] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
384 Barbut F, Collignon A, Butel MJ, Bourlioux P. [Fecal microbiota transplantation: review]. Ann Pharm Fr 2015;73:13-21. [PMID: 25577013 DOI: 10.1016/j.pharma.2014.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
385 Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108:478-98; quiz 499. [PMID: 23439232 DOI: 10.1038/ajg.2013.4] [Cited by in Crossref: 1051] [Cited by in F6Publishing: 862] [Article Influence: 116.8] [Reference Citation Analysis]
386 Li YT, Cai HF, Wang ZH, Xu J, Fang JY. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther. 2016;43:445-457. [PMID: 26662643 DOI: 10.1111/apt.13492] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 13.1] [Reference Citation Analysis]
387 . Faecal microbiota transplantation. Drug Ther Bull 2014;52:141-4. [PMID: 25505015 DOI: 10.1136/dtb.2014.12.0298] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
388 Perez E, Lee CH, Petrof EO. A Practical Method for Preparation of Fecal Microbiota Transplantation. Methods Mol Biol 2016;1476:259-67. [PMID: 27507347 DOI: 10.1007/978-1-4939-6361-4_19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
389 Mccollum DL, Rodriguez JM. Detection, Treatment, and Prevention of Clostridium difficile Infection. Clinical Gastroenterology and Hepatology 2012;10:581-92. [DOI: 10.1016/j.cgh.2012.03.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
390 Patel NC, Griesbach CL, DiBaise JK, Orenstein R. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience. Mayo Clin Proc. 2013;88:799-805. [PMID: 23910407 DOI: 10.1016/j.mayocp.2013.04.022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
391 Chen B, Avinashi V, Dobson S. Fecal microbiota transplantation for recurrent clostridium difficile infection in children. J Infect 2017;74 Suppl 1:S120-7. [PMID: 28646951 DOI: 10.1016/S0163-4453(17)30202-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
392 Kim KO, Schwartz MA, Lin OST, Chiorean MV, Gluck M. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection. Adv Ther 2019;36:2052-61. [PMID: 31154629 DOI: 10.1007/s12325-019-00974-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
393 Duarte-Chavez R, Wojda TR, Zanders TB, Geme B, Fioravanti G, Stawicki SP. Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital. J Glob Infect Dis 2018;10:47-57. [PMID: 29910564 DOI: 10.4103/jgid.jgid_145_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
394 Choi HH, Cho YS. Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc. 2016;49:257-265. [PMID: 26956193 DOI: 10.5946/ce.2015.117] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 19.7] [Reference Citation Analysis]
395 Lozupone CA, Stombaugh J, Gonzalez A, Ackermann G, Wendel D, Vázquez-Baeza Y, Jansson JK, Gordon JI, Knight R. Meta-analyses of studies of the human microbiota. Genome Res 2013;23:1704-14. [PMID: 23861384 DOI: 10.1101/gr.151803.112] [Cited by in Crossref: 268] [Cited by in F6Publishing: 246] [Article Influence: 29.8] [Reference Citation Analysis]
396 Fairhurst NG, Travis SPL. Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis? Intest Res 2018;16:209-15. [PMID: 29743833 DOI: 10.5217/ir.2018.16.2.209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
397 Pereira SG, Moura J, Carvalho E, Empadinhas N. Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies. Front Microbiol 2017;8:1791. [PMID: 28983285 DOI: 10.3389/fmicb.2017.01791] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
398 Villoslada-Blanco P, Pérez-Matute P, Oteo JA. Lights and Shadows of Microbiota Modulation and Cardiovascular Risk in HIV Patients. Int J Environ Res Public Health 2021;18:6837. [PMID: 34202210 DOI: 10.3390/ijerph18136837] [Reference Citation Analysis]
399 Bokoliya SC, Dorsett Y, Panier H, Zhou Y. Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies. Front Cell Infect Microbiol 2021;11:711055. [PMID: 34621688 DOI: 10.3389/fcimb.2021.711055] [Reference Citation Analysis]
400 Steele SR, Mccormick J, Melton GB, Paquette I, Rivadeneira DE, Stewart D, Buie WD, Rafferty J. Practice Parameters for the Management of Clostridium difficile Infection. Diseases of the Colon & Rectum 2015;58:10-24. [DOI: 10.1097/dcr.0000000000000289] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
401 Greenberg SA, Youngster I, Cohen NA, Livovsky DM, Strahilevitz J, Israeli E, Melzer E, Paz K, Fliss-Isakov N, Maharshak N. Five years of fecal microbiota transplantation - an update of the Israeli experience. World J Gastroenterol 2018; 24(47): 5403-5414 [PMID: 30598584 DOI: 10.3748/wjg.v24.i47.5403] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
402 Belizário JE, Faintuch J, Garay-Malpartida M. Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases. Mediators Inflamm 2018;2018:2037838. [PMID: 30622429 DOI: 10.1155/2018/2037838] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 19.5] [Reference Citation Analysis]
403 Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol 2016;14:609-20. [PMID: 27573580 DOI: 10.1038/nrmicro.2016.108] [Cited by in Crossref: 227] [Cited by in F6Publishing: 191] [Article Influence: 37.8] [Reference Citation Analysis]
404 Doré J, Simrén M, Buttle L, Guarner F. Hot topics in gut microbiota. United European Gastroenterol J. 2013;1:311-318. [PMID: 24917977 DOI: 10.1177/2050640613502477] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
405 Khan MY, Dirweesh A, Khurshid T, Siddiqui WJ. Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2018;30:1309-17. [DOI: 10.1097/meg.0000000000001243] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 6.8] [Reference Citation Analysis]
406 Mir S, Kellermayer R, Gulati AS. Pediatric Fecal Microbiota Transplantation. Curr Pediatr Rep 2014;2:227-34. [DOI: 10.1007/s40124-014-0049-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
407 Trubiano JA, Worth LJ, Thursky KA, Slavin MA. The prevention and management of infections due to multidrug resistant organisms in haematology patients. Br J Clin Pharmacol 2015;79:195-207. [PMID: 24341410 DOI: 10.1111/bcp.12310] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
408 Fernández L, Ruiz L, Jara J, Orgaz B, Rodríguez JM. Strategies for the Preservation, Restoration and Modulation of the Human Milk Microbiota. Implications for Human Milk Banks and Neonatal Intensive Care Units. Front Microbiol 2018;9:2676. [PMID: 30473683 DOI: 10.3389/fmicb.2018.02676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
409 Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O'Sullivan JM. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol 2016;6:15. [PMID: 26925392 DOI: 10.3389/fcimb.2016.00015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
410 Babacan NA, Tanvetyanon T. Superimposed Clostridium difficile Infection During Checkpoint Inhibitor Immunotherapy-induced Colitis. Journal of Immunotherapy 2019;42:350-3. [DOI: 10.1097/cji.0000000000000270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
411 Wing AC, Kremenchutzky M. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that? Benef Microbes 2019;10:27-32. [PMID: 30525949 DOI: 10.3920/BM2018.0029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
412 Brechmann T, Swol J, Knop-Hammad V, Willert J, Aach M, Cruciger O, Schmiegel W, Schildhauer TA, Hamsen U. Complicated fecal microbiota transplantation in a tetraplegic patient with severe Clostridium difficile infection. World J Gastroenterol 2015; 21(12): 3736-3740 [PMID: 25834343 DOI: 10.3748/wjg.v21.i12.3736] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
413 Yang Z, Schmidt D, Liu W, Li S, Shi L, Sheng J, Chen K, Yu H, Tremblay JM, Chen X, Piepenbrink KH, Sundberg EJ, Kelly CP, Bai G, Shoemaker CB, Feng H. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. J Infect Dis 2014;210:964-72. [PMID: 24683195 DOI: 10.1093/infdis/jiu196] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
414 Fehlbaum S, Chassard C, Poeker SA, Derrien M, Fourmestraux C, Lacroix C. Clostridium difficile colonization and antibiotics response in PolyFermS continuous model mimicking elderly intestinal fermentation. Gut Pathog 2016;8:63. [PMID: 27980686 DOI: 10.1186/s13099-016-0144-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
415 Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial. Ann Intern Med. 2016;165:609-616. [PMID: 27547925 DOI: 10.7326/m16-0271] [Cited by in Crossref: 307] [Cited by in F6Publishing: 155] [Article Influence: 51.2] [Reference Citation Analysis]
416 Zanella Terrier MC, Simonet ML, Bichard P, Frossard JL. Recurrent Clostridium difficile infections: The importance of the intestinal microbiota. World J Gastroenterol 2014; 20(23): 7416-7423 [PMID: 24966611 DOI: 10.3748/wjg.v20.i23.7416] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
417 Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313:398-408. [PMID: 25626036 DOI: 10.1001/jama.2014.17103] [Cited by in Crossref: 274] [Cited by in F6Publishing: 237] [Article Influence: 39.1] [Reference Citation Analysis]
418 Hsu WH, Wang JY, Kuo CH. Current applications of fecal microbiota transplantation in intestinal disorders. Kaohsiung J Med Sci 2019;35:327-31. [PMID: 31017741 DOI: 10.1002/kjm2.12069] [Reference Citation Analysis]
419 Brandt LJ. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection. Psychosom Med 2017;79:868-73. [DOI: 10.1097/psy.0000000000000511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
420 Jang MO, An JH, Jung SI, Park KH. Refractory Clostridium difficile Infection Cured With Fecal Microbiota Transplantation in Vancomycin-Resistant Enterococcus Colonized Patient. Intest Res 2015;13:80-4. [PMID: 25691847 DOI: 10.5217/ir.2015.13.1.80] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
421 Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61:181-206. [PMID: 25769243 DOI: 10.1016/j.disamonth.2015.01.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
422 Zhang X, Chen Y, Gu S, Zheng B, Lv T, Lou Y, Jin J. A case of multiple recurrence of Clostridium difficile infection with severe hematochezia in an immunocompromised host. Anaerobe 2016;42:31-2. [PMID: 27377777 DOI: 10.1016/j.anaerobe.2016.06.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
423 Guo WT, Dong LN, Wang JP, Liu P. New advances in clinical application of fecal microbiota transplantation. Shijie Huaren Xiaohua Zazhi 2014; 22(30): 4593-4598 [DOI: 10.11569/wcjd.v22.i30.4593] [Reference Citation Analysis]
424 Surawicz CM. Clostridium difficile infection: risk factors, diagnosis and management. Curr Treat Options Gastroenterol 2015;13:121-9. [PMID: 25567105 DOI: 10.1007/s11938-014-0038-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
425 Orenstein R, Griesbach CL, DiBaise JK. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract 2013;28:589-98. [PMID: 23979974 DOI: 10.1177/0884533613497516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
426 Simmerlein R, Basta A, Gosch M. Clostridium-difficile-Infektion bei geriatrischen Patienten. Z Gerontol Geriat 2016;49:743-61. [DOI: 10.1007/s00391-016-1143-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
427 Hwang IY, Koh E, Kim HR, Yew WS, Chang MW. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria. Drug Resistance Updates 2016;27:59-71. [DOI: 10.1016/j.drup.2016.06.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
428 Tran MC, Claros MC, Goldstein EJ. Therapy of Clostridium difficile infection: perspectives on a changing paradigm. Expert Opin Pharmacother 2013;14:2375-86. [PMID: 24053182 DOI: 10.1517/14656566.2013.838218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
429 Clayton JA, Toltzis P. Recent Issues in Pediatric Clostridium difficile Infection. Curr Infect Dis Rep 2017;19:49. [PMID: 29110105 DOI: 10.1007/s11908-017-0603-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
430 Schoster A, Weese JS, Guardabassi L. Probiotic use in horses - what is the evidence for their clinical efficacy? J Vet Intern Med 2014;28:1640-52. [PMID: 25231539 DOI: 10.1111/jvim.12451] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
431 Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljević T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A; European FMT Working Group. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66:569-80. [PMID: 28087657 DOI: 10.1136/gutjnl-2016-313017] [Cited by in Crossref: 425] [Cited by in F6Publishing: 365] [Article Influence: 85.0] [Reference Citation Analysis]
432 Yan FY, Ju J, Gao F, Wang XQ. Application of fecal microbiota transplantation in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(21): 3406-3412 [DOI: 10.11569/wcjd.v23.i21.3406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
433 Luo B, Zhang Y, Zhang C, Liu X, Shi C. Intestinal microbiota: A potential target for enhancing the antitumor efficacy and reducing the toxicity of immune checkpoint inhibitors. Cancer Lett 2021;509:53-62. [PMID: 33845122 DOI: 10.1016/j.canlet.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Madupu R, Szpakowski S, Nelson KE. Microbiome in human health and disease. Sci Prog 2013;96:153-70. [PMID: 23901633 DOI: 10.3184/003685013X13683759820813] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
435 Weinstock GM. Genomic approaches to studying the human microbiota. Nature. 2012;489:250-256. [PMID: 22972298 DOI: 10.1038/nature11553] [Cited by in Crossref: 299] [Cited by in F6Publishing: 244] [Article Influence: 29.9] [Reference Citation Analysis]
436 Carlet J. The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control 2012;1:39. [PMID: 23181506 DOI: 10.1186/2047-2994-1-39] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 10.2] [Reference Citation Analysis]
437 Kim JE, Gweon TG, Yeo CD, Cho YS, Kim GJ, Kim JY, Kim JW, Kim H, Lee HW, Lim T, Ham H, Oh HJ, Lee Y, Byeon J, Park SS. A case of Clostridium difficile infection complicated by acute respiratory distress syndrome treated with fecal microbiota transplantation. World J Gastroenterol 2014; 20(35): 12687-12690 [PMID: 25253977 DOI: 10.3748/wjg.v20.i35.12687] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
438 Luciano JA, Zuckerbraun BS. Clostridium difficile infection: prevention, treatment, and surgical management. Surg Clin North Am 2014;94:1335-49. [PMID: 25440127 DOI: 10.1016/j.suc.2014.08.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
439 de Vos W. Fame and Future of Fecal Transplantations: Developing Next-Generation Therapies with Synthetic Microbiomes. Health and the Gut. Apple Academic Press; 2014. pp. 339-61. [DOI: 10.1201/b17254-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
440 Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820 [PMID: 25356041 DOI: 10.3748/wjg.v20.i40.14805] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
441 Daliri EB, Tango CN, Lee BH, Oh D. Human microbiome restoration and safety. International Journal of Medical Microbiology 2018;308:487-97. [DOI: 10.1016/j.ijmm.2018.05.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
442 Aljarallah KM. Inhibition of Clostridium difficile by natural herbal extracts. Journal of Taibah University Medical Sciences 2016;11:427-31. [DOI: 10.1016/j.jtumed.2016.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Friedman-Korn T, Livovsky DM, Maharshak N, Aviv Cohen N, Paz K, Bar-Gil Shitrit A, Goldin E, Koslowsky B. Fecal Transplantation for Treatment of Clostridium Difficile Infection in Elderly and Debilitated Patients. Dig Dis Sci. 2018;63:198-203. [PMID: 29134299 DOI: 10.1007/s10620-017-4833-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
444 Wang J, Yang HR, Wang DJ, Wang XX. Association between the gut microbiota and patient responses to cancer immune checkpoint inhibitors. Oncol Lett 2020;20:342. [PMID: 33123253 DOI: 10.3892/ol.2020.12205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
445 Hota SS, Sales V, Tomlinson G, Salpeter MJ, Mcgeer A, Coburn B, Guttman DS, Low DE, Poutanen SM. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial. Clinical Infectious Diseases 2017;64:265-71. [DOI: 10.1093/cid/ciw731] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 16.2] [Reference Citation Analysis]
446 Mccune V, Struthers J, Hawkey P. Faecal transplantation for the treatment of Clostridium difficile infection: a review. International Journal of Antimicrobial Agents 2014;43:201-6. [DOI: 10.1016/j.ijantimicag.2013.10.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
447 Bernard R, Hourigan SK, Nicholson MR. Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients. J Pediatric Infect Dis Soc 2021;10:S58-63. [PMID: 34791396 DOI: 10.1093/jpids/piab056] [Reference Citation Analysis]
448 Lahti L, Salojärvi J, Salonen A, Scheffer M, de Vos WM. Tipping elements in the human intestinal ecosystem. Nat Commun 2014;5:4344. [PMID: 25003530 DOI: 10.1038/ncomms5344] [Cited by in Crossref: 142] [Cited by in F6Publishing: 121] [Article Influence: 17.8] [Reference Citation Analysis]
449 Wen YL, Niu JK, Miao YL. Non-drug treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(23): 3720-3728 [DOI: 10.11569/wcjd.v23.i23.3720] [Reference Citation Analysis]
450 Dutta SK, Girotra M, Garg S, Dutta A, von Rosenvinge EC, Maddox C, Song Y, Bartlett JG, Vinayek R, Fricke WF. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection. Clin Gastroenterol Hepatol. 2014;12:1572-1576. [PMID: 24440222 DOI: 10.1016/j.cgh.2013.12.032] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
451 Emanuelsson F, Claesson BE, Ljungström L, Tvede M, Ung KA. Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. Scand J Infect Dis 2014;46:89-97. [PMID: 24354958 DOI: 10.3109/00365548.2013.858181] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
452 Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:503-516. [PMID: 22827693 DOI: 10.1111/j.1365-2036.2012.05220.x] [Cited by in Crossref: 207] [Cited by in F6Publishing: 191] [Article Influence: 20.7] [Reference Citation Analysis]
453 Belga S, Chiang D, Kabbani D, Abraldes JG, Cervera C. The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients. Expert Rev Anti Infect Ther 2019;17:363-73. [PMID: 30977692 DOI: 10.1080/14787210.2019.1607297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
454 Walshe N, Mulcahy G, Hodgkinson J, Peachey L. No Worm Is an Island; The Influence of Commensal Gut Microbiota on Cyathostomin Infections. Animals (Basel) 2020;10:E2309. [PMID: 33291496 DOI: 10.3390/ani10122309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
455 Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014;48:693-702. [PMID: 24440934 DOI: 10.1097/mcg.0000000000000046] [Cited by in Crossref: 245] [Cited by in F6Publishing: 121] [Article Influence: 35.0] [Reference Citation Analysis]
456 Moura IB, Normington C, Ewin D, Clark E, Wilcox MH, Buckley AM, Chilton CH. Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon. BMC Microbiol 2020;20:2. [PMID: 31898476 DOI: 10.1186/s12866-019-1669-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
457 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: Joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67:1920-1941. [PMID: 30154172 DOI: 10.1136/gutjnl-2018-316818] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 31.5] [Reference Citation Analysis]
458 García-garcía-de-paredes A, Rodríguez-de-santiago E, Aguilera-castro L, Ferre-aracil C, López-sanromán A. Trasplante de microbiota fecal. Gastroenterología y Hepatología 2015;38:123-34. [DOI: 10.1016/j.gastrohep.2014.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
459 Liu S, Guo R, Liu F, Yuan Q, Yu Y, Ren F. Gut Microbiota Regulates Depression-Like Behavior in Rats Through the Neuroendocrine-Immune-Mitochondrial Pathway. Neuropsychiatr Dis Treat 2020;16:859-69. [PMID: 32280227 DOI: 10.2147/NDT.S243551] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
460 Giau VV, Lee H, An SSA, Hulme J. Recent advances in the treatment of C. difficile using biotherapeutic agents. Infect Drug Resist 2019;12:1597-615. [PMID: 31354309 DOI: 10.2147/IDR.S207572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
461 Padua D, Pothoulakis C. Novel approaches to treating Clostridium difficile-associated colitis. Expert Rev Gastroenterol Hepatol 2016;10:193-204. [PMID: 26643655 DOI: 10.1586/17474124.2016.1109444] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
462 Borgia G, Maraolo AE, Foggia M, Buonomo AR, Gentile I. Fecal microbiota transplantation for Clostridium difficile infection: back to the future. Expert Opin Biol Ther. 2015;15:1001-1014. [PMID: 26063385 DOI: 10.1517/14712598.2015.1045872] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
463 Garajová I, Balsano R, Wang H, Leonardi F, Giovannetti E, Deng D, Peters GJ. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Rev Anticancer Ther 2021;21:165-76. [PMID: 33115280 DOI: 10.1080/14737140.2021.1844007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
464 Culligan EP, Sleator RD. Advances in the Microbiome: Applications to Clostridium difficile Infection. J Clin Med 2016;5:E83. [PMID: 27657145 DOI: 10.3390/jcm5090083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
465 Colenutt C, Cutting SM. Use of Bacillus subtilis PXN21 spores for suppression of Clostridium difficile infection symptoms in a murine model. FEMS Microbiol Lett 2014;358:154-61. [PMID: 24828432 DOI: 10.1111/1574-6968.12468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
466 Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013;7:245-257. [PMID: 23734647 DOI: 10.1586/ers.13.24] [Cited by in Crossref: 211] [Cited by in F6Publishing: 195] [Article Influence: 26.4] [Reference Citation Analysis]
467 Miraglia F, Colla E. Microbiome, Parkinson's Disease and Molecular Mimicry. Cells 2019;8:E222. [PMID: 30866550 DOI: 10.3390/cells8030222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
468 Ferrer Márquez M, Hernández Martínez Á, Reina Duarte Á, Rosado Cobián R. Current Status of the Treatment of Fulminant Colitis. Cir Esp 2015;93:276-82. [PMID: 25649534 DOI: 10.1016/j.ciresp.2014.09.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
469 Evrensel A, Ceylan ME. Fecal Microbiota Transplantation in the Treatment-Resistant Psychiatric Disorders. In: Kim Y, editor. Treatment Resistance in Psychiatry. Singapore: Springer; 2019. pp. 369-76. [DOI: 10.1007/978-981-10-4358-1_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
470 Carrière J, Darfeuille-Michaud A, Nguyen HTT. Infectious etiopathogenesis of Crohn’s disease. World J Gastroenterol 2014; 20(34): 12102-12117 [PMID: 25232246 DOI: 10.3748/wjg.v20.i34.12102] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
471 Agarwal A, Maheshwari A, Verma S, Arrup D, Phillips L, Vinayek R, Nair P, Hagan M, Dutta S. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis. Dig Dis Sci 2021;66:2000-4. [PMID: 32656604 DOI: 10.1007/s10620-020-06459-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
472 Fischer M, Sipe BW, Rogers NA, Cook GK, Robb BW, Vuppalanchi R, Rex DK. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 2015;42:470-6. [PMID: 26096320 DOI: 10.1111/apt.13290] [Cited by in Crossref: 110] [Cited by in F6Publishing: 84] [Article Influence: 15.7] [Reference Citation Analysis]
473 Khan MAW, Ologun G, Arora R, McQuade JL, Wargo JA. Gut Microbiome Modulates Response to Cancer Immunotherapy. Dig Dis Sci 2020;65:885-96. [PMID: 32067144 DOI: 10.1007/s10620-020-06111-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
474 Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes. 2013;4:53-65. [PMID: 23257018 DOI: 10.3920/bm2012.0039] [Cited by in Crossref: 83] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
475 Bellali S, Bou Khalil J, Fontanini A, Raoult D, Lagier JC. A new protectant medium preserving bacterial viability after freeze drying. Microbiol Res 2020;236:126454. [PMID: 32200250 DOI: 10.1016/j.micres.2020.126454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
476 Zhang L, Chu J, Hao W, Zhang J, Li H, Yang C, Yang J, Chen X, Wang H. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications. Mediators Inflamm 2021;2021:5110276. [PMID: 34447287 DOI: 10.1155/2021/5110276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
477 Hirsch BE, Saraiya N, Poeth K, Schwartz RM, Epstein ME, Honig G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis 2015;15:191. [PMID: 25885020 DOI: 10.1186/s12879-015-0930-z] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 13.9] [Reference Citation Analysis]
478 Sunkara T, Rawla P, Ofosu A, Gaduputi V. Fecal microbiota transplant - a new frontier in inflammatory bowel disease. J Inflamm Res 2018;11:321-8. [PMID: 30214266 DOI: 10.2147/JIR.S176190] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
479 Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, MacNair CR, French S, Carfrae LA, Bloom-Ackermann Z, Tran VM, Chiappino-Pepe A, Badran AH, Andrews IW, Chory EJ, Church GM, Brown ED, Jaakkola TS, Barzilay R, Collins JJ. A Deep Learning Approach to Antibiotic Discovery. Cell 2020;180:688-702.e13. [PMID: 32084340 DOI: 10.1016/j.cell.2020.01.021] [Cited by in Crossref: 274] [Cited by in F6Publishing: 208] [Article Influence: 137.0] [Reference Citation Analysis]
480 Vindigni SM, Surawicz CM. Fecal Microbiota Transplantation. Gastroenterol Clin North Am. 2017;46:171-185. [PMID: 28164849 DOI: 10.1016/j.gtc.2016.09.012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 19.3] [Reference Citation Analysis]
481 Costello SP, Tucker EC, La Brooy J, Schoeman MN, Andrews JM. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection. Clin Infect Dis 2016;62:908-14. [PMID: 26628567 DOI: 10.1093/cid/civ994] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 8.9] [Reference Citation Analysis]
482 Ray A, Jones C. Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection. Future Microbiology 2016;11:611-6. [DOI: 10.2217/fmb.16.10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
483 Inamura K. Roles of microbiota in response to cancer immunotherapy. Semin Cancer Biol 2020;65:164-75. [PMID: 31911189 DOI: 10.1016/j.semcancer.2019.12.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
484 Broecker F, Klumpp J, Moelling K. Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection. Ann N Y Acad Sci 2016;1372:29-41. [PMID: 27286042 DOI: 10.1111/nyas.13100] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
485 Theriot CM, Young VB. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes 2014;5:86-95. [PMID: 24335555 DOI: 10.4161/gmic.27131] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
486 Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138:1-11. [PMID: 23240815 DOI: 10.1111/j.1365-2567.2012.03616.x] [Cited by in Crossref: 307] [Cited by in F6Publishing: 259] [Article Influence: 34.1] [Reference Citation Analysis]
487 Fischer M, Kao D, Kelly C, Kuchipudi A, Jafri SM, Blumenkehl M, Rex D, Mellow M, Kaur N, Sokol H. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:2402-2409. [PMID: 27580384 DOI: 10.1097/mib.0000000000000908] [Cited by in Crossref: 88] [Cited by in F6Publishing: 49] [Article Influence: 22.0] [Reference Citation Analysis]
488 Kelly KN, Monson JR. Hospital-acquired infections. Surgery (Oxford) 2012;30:640-4. [DOI: 10.1016/j.mpsur.2012.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
489 Miller AW, Dearing D. The metabolic and ecological interactions of oxalate-degrading bacteria in the Mammalian gut. Pathogens 2013;2:636-52. [PMID: 25437337 DOI: 10.3390/pathogens2040636] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
490 Duke PS, Fardy J. Recurrent Clostridium difficile infection treated with home fecal transplantation: a case report. J Med Case Rep 2014;8:393. [PMID: 25430511 DOI: 10.1186/1752-1947-8-393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
491 Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis. 2012;55:1652-1658. [PMID: 22990849 DOI: 10.1093/cid/cis809] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 10.8] [Reference Citation Analysis]
492 Bittinger M, Messmann H. [Chronic critically ill patients from a gastroenterological perspective]. Med Klin Intensivmed Notfmed 2013;108:285-9. [PMID: 23423578 DOI: 10.1007/s00063-012-0195-x] [Reference Citation Analysis]
493 van Nood E, Speelman P, Nieuwdorp M, Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol. 2014;30:34-39. [PMID: 24241245 DOI: 10.1097/mog.0000000000000024] [Cited by in Crossref: 64] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
494 Badger VO, Ledeboer NA, Graham MB, Edmiston CE. Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen. JPEN J Parenter Enteral Nutr. 2012;36:645-662. [PMID: 22577120 DOI: 10.1177/0148607112446703] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
495 Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079-1087. [PMID: 22450732 DOI: 10.1038/ajg.2012.60] [Cited by in Crossref: 458] [Cited by in F6Publishing: 395] [Article Influence: 45.8] [Reference Citation Analysis]
496 LaCourse KD, Johnston CD, Bullman S. The relationship between gastrointestinal cancers and the microbiota. Lancet Gastroenterol Hepatol 2021;6:498-509. [PMID: 33743198 DOI: 10.1016/S2468-1253(20)30362-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
497 Cookson WOCM, Cox MJ, Moffatt MF. New opportunities for managing acute and chronic lung infections. Nat Rev Microbiol 2018;16:111-20. [PMID: 29062070 DOI: 10.1038/nrmicro.2017.122] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
498 Lin TC, Hung YP, Ko WC, Ruan JW. Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation. J Microbiol Immunol Infect 2019;52:841-50. [PMID: 31607571 DOI: 10.1016/j.jmii.2019.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
499 Saeedi BJ, Morison DG, Kraft CS, Dhere T. Fecal Microbiota Transplant for Clostridium difficile Infection in a Pregnant Patient. Obstetrics & Gynecology 2017;129:507-9. [DOI: 10.1097/aog.0000000000001911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
500 Wang L, Chen C, Cui S, Lee YK, Wang G, Zhao J, Zhang H, Chen W. Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice. Front Microbiol 2019;10:1721. [PMID: 31456752 DOI: 10.3389/fmicb.2019.01721] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
501 Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. J Hosp Infect. 2018;100 Suppl 1:S1-S31. [PMID: 30173851 DOI: 10.1016/j.jhin.2018.07.037] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
502 Di Bella S, Drapeau C, García-Almodóvar E, Petrosillo N. Fecal microbiota transplantation: the state of the art. Infect Dis Rep. 2013;5:e13. [PMID: 24470963 DOI: 10.4081/idr.2013.e13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
503 Martz SL, Guzman-Rodriguez M, He SM, Noordhof C, Hurlbut DJ, Gloor GB, Carlucci C, Weese S, Allen-Vercoe E, Sun J, Claud EC, Petrof EO. A human gut ecosystem protects against C. difficile disease by targeting TcdA. J Gastroenterol 2017;52:452-65. [PMID: 27329502 DOI: 10.1007/s00535-016-1232-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
504 Seekatz AM, Theriot CM, Molloy CT, Wozniak KL, Bergin IL, Young VB. Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease. Infect Immun 2015;83:3838-46. [PMID: 26169276 DOI: 10.1128/IAI.00459-15] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 11.3] [Reference Citation Analysis]
505 Rao K, Higgins PD. Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1744-54. [PMID: 27120571 DOI: 10.1097/MIB.0000000000000793] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
506 Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol. 2013;48:995-1009. [PMID: 23964766 DOI: 10.3109/00365521.2013.799220] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
507 Green JE, Davis JA, Berk M, Hair C, Loughman A, Castle D, Athan E, Nierenberg AA, Cryan JF, Jacka F, Marx W. Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes 2020;12:1-25. [PMID: 33345703 DOI: 10.1080/19490976.2020.1854640] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
508 Pigneur B, Sokol H. Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail. Mucosal Immunol. 2016;9:1360-1365. [PMID: 27461176 DOI: 10.1038/mi.2016.67] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
509 Gao Z, Kang Y, Yu J, Ren L. Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genomics Proteomics Bioinformatics 2014;12:144-50. [PMID: 24953866 DOI: 10.1016/j.gpb.2014.06.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
510 Nitzan M, Mintzer S, Margalit H. Approaches and developments in studying the human microbiome network. Israel J Ecol Evol 2015;61:90-4. [DOI: 10.1080/15659801.2015.1042768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
511 Bermejo C, Maseda E, Salgado P, Gabilondo G, Gilsanz F. [Septic shock due to a community acquired Clostridium difficile infection. A case study and a review of the literature]. Rev Esp Anestesiol Reanim 2014;61:219-22. [PMID: 23735318 DOI: 10.1016/j.redar.2013.04.005] [Reference Citation Analysis]
512 Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014;68:363-8. [DOI: 10.1111/ijcp.12320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
513 Solomon K. The host immune response to Clostridium difficile infection. Ther Adv Infect Dis. 2013;1:19-35. [PMID: 25165542 DOI: 10.1177/2049936112472173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
514 Seekatz AM, Young VB. Clostridium difficile and the microbiota. J Clin Invest 2014;124:4182-9. [PMID: 25036699 DOI: 10.1172/JCI72336] [Cited by in Crossref: 137] [Cited by in F6Publishing: 75] [Article Influence: 17.1] [Reference Citation Analysis]
515 Hourigan SK, Oliva-Hemker M. Fecal microbiota transplantation in children: a brief review. Pediatr Res. 2016;80:2-6. [PMID: 26982451 DOI: 10.1038/pr.2016.48] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
516 Cheng YW, Fischer M. Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime? Gastroenterol Clin North Am 2020;49:739-52. [PMID: 33121693 DOI: 10.1016/j.gtc.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
517 Ruppé E, Andremont A. Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria. Front Microbiol 2013;4:129. [PMID: 23755045 DOI: 10.3389/fmicb.2013.00129] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
518 Khoruts A, Sadowsky MJ, Hamilton MJ. Development of fecal microbiota transplantation suitable for mainstream medicine. Clin Gastroenterol Hepatol 2015;13:246-50. [PMID: 25460566 DOI: 10.1016/j.cgh.2014.11.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
519 Mizusawa M, Doron S, Gorbach S. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options. Drugs Aging 2015;32:639-47. [DOI: 10.1007/s40266-015-0289-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
520 Vindigni SM, Surawicz CM. C. difficile Infection: Changing Epidemiology and Management Paradigms. Clin Transl Gastroenterol. 2015;6:e99. [PMID: 26158611 DOI: 10.1038/ctg.2015.24] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
521 Witkowski M, Witkowski M, Gagliani N, Huber S. Recipe for IBD: can we use food to control inflammatory bowel disease? Semin Immunopathol 2018;40:145-56. [PMID: 29124320 DOI: 10.1007/s00281-017-0658-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
522 Marzano M, Fosso B, Piancone E, Defazio G, Pesole G, De Robertis M. Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer. Cancers (Basel) 2021;13:996. [PMID: 33673612 DOI: 10.3390/cancers13050996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
523 Bakken JS, Polgreen PM, Beekmann SE, Riedo FX, Streit JA. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Anaerobe 2013;24:20-4. [PMID: 24012687 DOI: 10.1016/j.anaerobe.2013.08.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
524 Keller PM, Weber MH. Rational Therapy of Clostridium difficile Infections. Viszeralmedizin 2014;30:304-9. [PMID: 26288096 DOI: 10.1159/000366302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
525 Rajasingham R, Enns EA, Khoruts A, Vaughn BP. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines. Clin Infect Dis 2020;70:754-62. [PMID: 31001619 DOI: 10.1093/cid/ciz318] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
526 Couture-Cossette A, Carignan A, Ilangumaran S, Valiquette L. Bezlotoxumab for the prevention of Clostridium difficile recurrence. Expert Opin Biol Ther 2017;17:1439-45. [PMID: 28805081 DOI: 10.1080/14712598.2017.1363886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
527 Lübbert C, John E, von Müller L. Clostridium difficile infection: guideline-based diagnosis and treatment. Dtsch Arztebl Int. 2014;111:723-731. [PMID: 25404529 DOI: 10.3238/arztebl.2014.0723] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
528 Lai CY, Sung J, Cheng F, Tang W, Wong SH, Chan PKS, Kamm MA, Sung JJY, Kaplan G, Chan FKL, Ng SC. Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation. Aliment Pharmacol Ther. 2019;49:354-363. [PMID: 30628108 DOI: 10.1111/apt.15116] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
529 Berg D, Clemente JC, Colombel JF. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome? Expert Rev Gastroenterol Hepatol. 2015;9:781-795. [PMID: 25665875 DOI: 10.1586/17474124.2015.1013031] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
530 Kumar PS, Mason MR. Mouthguards: does the indigenous microbiome play a role in maintaining oral health? Front Cell Infect Microbiol 2015;5:35. [PMID: 26000251 DOI: 10.3389/fcimb.2015.00035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
531 Turroni F, Ventura M, Buttó LF, Duranti S, O'Toole PW, Motherway MO, van Sinderen D. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 2014;71:183-203. [PMID: 23516017 DOI: 10.1007/s00018-013-1318-0] [Cited by in Crossref: 163] [Cited by in F6Publishing: 149] [Article Influence: 18.1] [Reference Citation Analysis]
532 Paramsothy S, Walsh AJ, Borody T, Samuel D, van den Bogaerde J, Leong RW, Connor S, Ng W, Mitchell HM, Kaakoush NO, Kamm MA. Gastroenterologist perceptions of faecal microbiota transplantation. World J Gastroenterol 2015; 21(38): 10907-10914 [PMID: 26478682 DOI: 10.3748/wjg.v21.i38.10907] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
533 Pellicano C, Leodori G, Innocenti GP, Gigante A, Rosato E. Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes? Nutrients 2019;11:E2629. [PMID: 31684052 DOI: 10.3390/nu11112629] [Reference Citation Analysis]
534 Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes. 2012;3:121-134. [PMID: 22555464 DOI: 10.4161/gmic.19399] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 12.1] [Reference Citation Analysis]
535 Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant 2019;19:501-11. [PMID: 30085388 DOI: 10.1111/ajt.15058] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 12.8] [Reference Citation Analysis]
536 Rao K, Erb-Downward JR, Walk ST, Micic D, Falkowski N, Santhosh K, Mogle JA, Ring C, Young VB, Huffnagle GB, Aronoff DM. The systemic inflammatory response to Clostridium difficile infection. PLoS One 2014;9:e92578. [PMID: 24643077 DOI: 10.1371/journal.pone.0092578] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
537 Davidovics ZH, Hyams JS. Fecal transplantation: re-discovering the value of stool. Current Opinion in Pediatrics 2013;25:618-23. [DOI: 10.1097/mop.0b013e328363ed66] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
538 Merrick B, Robinson E, Bunce C, Allen L, Bisnauthsing K, Izundu CC, Bell J, Amos G, Shankar-Hari M, Goodman A, Shawcross DL, Goldenberg SD. Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial. BMJ Open 2020;10:e038847. [PMID: 32457083 DOI: 10.1136/bmjopen-2020-038847] [Reference Citation Analysis]
539 Browne HP, Neville BA, Forster SC, Lawley TD. Transmission of the gut microbiota: spreading of health. Nat Rev Microbiol. 2017;15:531-543. [PMID: 28603278 DOI: 10.1038/nrmicro.2017.50] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 15.8] [Reference Citation Analysis]
540 Vyas D, L’Esperance HE, Vyas A. Stool therapy may become a preferred treatment of recurrent Clostridium difficileWorld J Gastroenterol 2013; 19(29): 4635-4637 [PMID: 23922461 DOI: 10.3748/wjg.v19.i29.4635] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
541 Luz MRMPD, Waizbort RF. [Fecal microbiota transplants in the treatment of pseudomembranous colitis (1958-2013): priority of discovery and thought styles in the academic literature]. Hist Cienc Saude Manguinhos 2020;27:859-78. [PMID: 33111793 DOI: 10.1590/S0104-59702020000400009] [Reference Citation Analysis]
542 Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013;145:946-953. [PMID: 24018052 DOI: 10.1053/j.gastro.2013.08.058] [Cited by in Crossref: 350] [Cited by in F6Publishing: 304] [Article Influence: 38.9] [Reference Citation Analysis]
543 Yakob L, Riley TV, Paterson DL, Marquess J, Clements AC. Assessing control bundles for Clostridium difficile: a review and mathematical model. Emerg Microbes Infect 2014;3:e43. [PMID: 26038744 DOI: 10.1038/emi.2014.43] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
544 Lau HCH, Sung JJ, Yu J. Gut microbiota: impacts on gastrointestinal cancer immunotherapy. Gut Microbes 2021;13:1-21. [PMID: 33435800 DOI: 10.1080/19490976.2020.1869504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
545 Ooijevaar R, van Beurden Y, Terveer E, Goorhuis A, Bauer M, Keller J, Mulder C, Kuijper E. Update of treatment algorithms for Clostridium difficile infection. Clinical Microbiology and Infection 2018;24:452-62. [DOI: 10.1016/j.cmi.2017.12.022] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 15.8] [Reference Citation Analysis]
546 Russell GH, Kaplan JL, Youngster I, Baril-Dore M, Schindelar L, Hohmann E, Winter HS. Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;58:588-592. [PMID: 24792627 DOI: 10.1097/mpg.0000000000000283] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 5.4] [Reference Citation Analysis]
547 Vujkovic-Cvijin I, Somsouk M. HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration. Curr HIV/AIDS Rep 2019;16:204-13. [PMID: 31037552 DOI: 10.1007/s11904-019-00441-w] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
548 Ren RR, Sun G, Yang YS, Peng LH, Wang SF, Shi XH, Zhao JQ, Ban YL, Pan F, Wang XH, Lu W, Ren JL, Song Y, Wang JB, Lu QM, Bai WY, Wu XP, Wang ZK, Zhang XM, Chen Y. Chinese physicians’ perceptions of fecal microbiota transplantation. World J Gastroenterol 2016; 22(19): 4757-4765 [PMID: 27217707 DOI: 10.3748/wjg.v22.i19.4757] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
549 Jump RL. Clostridium difficile infection in older adults. Aging health 2013;9:403-14. [PMID: 24955106 DOI: 10.2217/ahe.13.37] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
550 Vaishnavi C. Fecal microbiota transplantation for management of Clostridium difficile infection. Indian J Gastroenterol 2014;33:301-7. [PMID: 24748025 DOI: 10.1007/s12664-014-0459-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
551 Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med 2019;25:377-88. [DOI: 10.1038/s41591-019-0377-7] [Cited by in Crossref: 250] [Cited by in F6Publishing: 218] [Article Influence: 83.3] [Reference Citation Analysis]
552 Allen-Vercoe E, Reid G, Viner N, Gloor GB, Hota S, Kim P, Lee C, O'Doherty K, Vanner SJ, Weese JS, Petrof EO. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can J Gastroenterol 2012;26:457-62. [PMID: 22803022 DOI: 10.1155/2012/213828] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
553 Vergine M, Meyer JB, Cardinale M, Sabella E, Hartmann M, Cherubini P, De Bellis L, Luvisi A. The Xylella fastidiosa-Resistant Olive Cultivar "Leccino" Has Stable Endophytic Microbiota during the Olive Quick Decline Syndrome (OQDS). Pathogens 2019;9:E35. [PMID: 31906093 DOI: 10.3390/pathogens9010035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
554 Tetz G, Tetz V. Introducing the sporobiota and sporobiome. Gut Pathog. 2017;9:38. [PMID: 28680484 DOI: 10.1186/s13099-017-0187-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
555 Inamura K. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Semin Cancer Biol 2021;70:11-23. [PMID: 32580023 DOI: 10.1016/j.semcancer.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
556 Kamada N, Chen G, Núñez G. A complex microworld in the gut: Harnessing pathogen-commensal relations. Nat Med 2012;18:1190-1. [PMID: 22869189 DOI: 10.1038/nm.2900] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
557 Waite DW, Deines P, Taylor MW. Quantifying the impact of storage procedures for faecal bacteriotherapy in the critically endangered New Zealand Parrot, the Kakapo ( Strigops habroptilus ): Quantifying the Impact of Storage Procedures. Zoo Biology 2013;32:620-5. [DOI: 10.1002/zoo.21098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
558 Chong PP, Koh AY. The gut microbiota in transplant patients. Blood Rev 2020;39:100614. [PMID: 31492463 DOI: 10.1016/j.blre.2019.100614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
559 Zamudio-tiburcio Á, Bermúdez-ruiz H, Lezama-guzmán HR, Guevara-ortigoza MDP, Islas-solares E, Sosa-lópez FA. Rompiendo paradigmas. Trasplante de microbiota intestinal: reporte preliminar. Cirugía y Cirujanos 2017;85:6-12. [DOI: 10.1016/j.circir.2016.11.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
560 Taur Y, Pamer EG. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 2013;26:332-7. [PMID: 23806896 DOI: 10.1097/QCO.0b013e3283630dd3] [Cited by in Crossref: 83] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
561 Núñez F P, Quera R, Bay C, Thomson P. Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00192-8. [PMID: 34118321 DOI: 10.1016/j.gastrohep.2021.05.009] [Reference Citation Analysis]
562 Aldrich AM, Argo T, Koehler TJ, Olivero R. Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital. Pediatr Infect Dis J 2019;38:32-6. [PMID: 29601446 DOI: 10.1097/INF.0000000000002053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
563 Hesta M, Costa M. How Can Nutrition Help with Gastrointestinal Tract-Based Issues? Vet Clin North Am Equine Pract 2021;37:63-87. [PMID: 33820610 DOI: 10.1016/j.cveq.2020.12.007] [Reference Citation Analysis]
564 Pacheco SM, Johnson S. Important clinical advances in the understanding of Clostridium difficile infection. Curr Opin Gastroenterol 2013;29:42-8. [PMID: 23207596 DOI: 10.1097/MOG.0b013e32835a68d4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
565 Di Bella S, Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother. 2015;21:230-237. [PMID: 25703532 DOI: 10.1016/j.jiac.2015.01.011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
566 Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease. J Clin Gastroenterol 2014;48 Suppl 1:S80-4. [PMID: 25291136 DOI: 10.1097/MCG.0000000000000244] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
567 Seril DN, Shen B. Clostridium difficile Infection in Patients With Ileal Pouches. American Journal of Gastroenterology 2014;109:941-7. [DOI: 10.1038/ajg.2014.22] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
568 Shin JY, Ko EJ, Lee SH, Shin JB, Kim SI, Kwon KS, Kim HG, Shin YW, Bang BW. Refractory pseudomembranous colitis that was treated successfully with colonoscopic fecal microbial transplantation. Intest Res 2016;14:83-8. [PMID: 26884739 DOI: 10.5217/ir.2016.14.1.83] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
569 Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol. 2014;306:G310-G319. [PMID: 24284963 DOI: 10.1152/ajpgi.00282.2013] [Cited by in Crossref: 236] [Cited by in F6Publishing: 220] [Article Influence: 26.2] [Reference Citation Analysis]
570 Guo X, Yang X, Li Q, Shen X, Zhong H, Yang Y. The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics. Front Pharmacol 2021;12:759095. [PMID: 34887760 DOI: 10.3389/fphar.2021.759095] [Reference Citation Analysis]
571 Kort R. Personalized therapy with probiotics from the host by TripleA. Trends Biotechnol 2014;32:291-3. [PMID: 24785330 DOI: 10.1016/j.tibtech.2014.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
572 Taggart H, Bergstrom L. An Overview of the Microbiome and the Effects of Antibiotics. The Journal for Nurse Practitioners 2014;10:445-50. [DOI: 10.1016/j.nurpra.2014.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
573 Lo Vecchio A, Cohen MB. Fecal microbiota transplantation for Clostridium difficile infection: benefits and barriers. Curr Opin Gastroenterol. 2014;30:47-53. [PMID: 24275671 DOI: 10.1097/mog.0000000000000023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
574 Sheehan D, Shanahan F. The Gut Microbiota in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:143-54. [PMID: 28164847 DOI: 10.1016/j.gtc.2016.09.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 8.8] [Reference Citation Analysis]
575 Garsin DA, Lorenz MC. Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism? Gut Microbes 2013;4:409-15. [PMID: 23941906 DOI: 10.4161/gmic.26040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
576 Hensley BJ, Monson JR. Hospital-acquired infections. Surgery (Oxford) 2015;33:528-33. [DOI: 10.1016/j.mpsur.2015.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
577 Porter R, Fogg C. Faecal microbiota transplantation for Clostridium difficile infection in the United Kingdom. Clinical Microbiology and Infection 2015;21:578-82. [DOI: 10.1016/j.cmi.2015.01.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
578 Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013;15:337. [PMID: 23852569 DOI: 10.1007/s11894-013-0337-1] [Cited by in Crossref: 143] [Cited by in F6Publishing: 123] [Article Influence: 17.9] [Reference Citation Analysis]
579 Seekatz AM, Rao K, Santhosh K, Young VB. Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection. Genome Med. 2016;8:47. [PMID: 27121861 DOI: 10.1186/s13073-016-0298-8] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
580 De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019;195:74-85. [PMID: 29920643 DOI: 10.1111/cei.13158] [Cited by in Crossref: 110] [Cited by in F6Publishing: 90] [Article Influence: 36.7] [Reference Citation Analysis]
581 Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of Clostridium difficile infections. Am J Med 2014;127:479-83. [PMID: 24582877 DOI: 10.1016/j.amjmed.2014.02.017] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
582 Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev. 2013;26:604-630. [PMID: 23824374 DOI: 10.1128/cmr.00016-13] [Cited by in Crossref: 248] [Cited by in F6Publishing: 120] [Article Influence: 31.0] [Reference Citation Analysis]
583 Martinez C, Edwards J, Hassoun A. Commercialized fecal microbiota transplantation provides efficacious treatment of Clostridium difficile infection. Infect Dis (Lond) 2018;50:864-7. [PMID: 30265170 DOI: 10.1080/23744235.2018.1500709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
584 Kettelhut A, Bowman E, Funderburg NT. Immunomodulatory and Anti-Inflammatory Strategies to Reduce Comorbidity Risk in People with HIV. Curr HIV/AIDS Rep 2020;17:394-404. [PMID: 32535769 DOI: 10.1007/s11904-020-00509-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
585 Tariq R, Pardi DS, Bartlett MG, Khanna S. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis. Clin Infect Dis. 2019;68:1351-1358. [PMID: 30957161 DOI: 10.1093/cid/ciy721] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 30.5] [Reference Citation Analysis]
586 Cheng YW, Phelps E, Nemes S, Rogers N, Sagi S, Bohm M, El-Halabi M, Allegretti JR, Kassam Z, Xu H, Fischer M. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection. Clin Gastroenterol Hepatol 2020;18:2234-2243.e1. [PMID: 31923639 DOI: 10.1016/j.cgh.2019.12.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
587 Terveer EM, van Beurden YH, van Dorp S, Keller JJ, Kuijper EJ. Is the Lower Gastrointestinal Route Really Preferred Over the Upper Gastrointestinal Route for Fecal Microbiota Transfer? Journal of Clinical Gastroenterology 2016;50:895-895. [DOI: 10.1097/mcg.0000000000000595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
588 Park R, Umar S, Kasi A. Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-augmented Clinical Trials. Curr Colorectal Cancer Rep 2020;16:81-8. [PMID: 32607098 DOI: 10.1007/s11888-020-00456-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]